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The Przewalski’s horse (Equus ferus przewalskii) once roamed the Eurasian Steppe but 
is now considered Critically Endangered with only 1872 individuals remaining in the world, 
representing progeny from only 14 founder animals (Lee and Boyd, 2008).  Genetic diversity 
needs to be optimal for long term survival of this species.  Unfortunately, increasing genetic 
diversity of the captive population in North America has been hindered by a decrease in 
fertility.  Therefore, the main focus of this research was to characterize reproductive 
parameters in Przewalski’s horse, including estrus cycle in mares and  seminal traits in 
stallions, and determining whether age or inbreeding had an impact on these traits.  A 
secondary focus was to determine whether hormone manipulation of the estrous cycle in 
mares could be utilized for the long-term goal of using artificial insemination as a breeding 
management tool for this species.  To facilitate these studies, a technique for palpation of 
Przewalski’s mares was developed; the first application of such a procedure in a wild equid.  
Subsequently, we were able to describe follicular changes in relation to urinary hormone 
patterns.  Fifty percent of the mares had either irregular or acyclic hormonal and follicular 
patterns. These patterns were directly correlated with inbreeding which is the first time such a 
correlation has been described in this species. Estrous manipulation was possible using an 
injectable biorelease form of the progestagen, altrenogest.   In stallions, we developed a 
reliable method of semen collection for Przewalski’s stallions and, as a result, describe 
seminal traits from 98 semen collections from 14 stallions.  Based on these collections, we 
were able to show that sub-fertility in this population could be due to the low percentage of 
normal spermatozoa.   Based on variable analysis, seminal traits total concentration, volume 
and morphology showed variable changes through the year. Traits also varied on an 
individual stallion basis. Together, these studies demonstrated that inbreeding is detrimentally 
affecting the reproductive fitness of this species and that aggressive management is needed 
for long term sustainability of the captive population.
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The Asian Wild Horse
Small and pony-like in stature, dun colored with a dark upright mane, the 
Przewalski’s horse is a distant cousin to the domestic horse (Equus caballus). It is now 
believed that the Przewalski’s horse shares a common ancestor to the domestic 
counterpart, but the former have 66 chromosomes compared to 64 in the latter (Ryder, 
1994).  Once thought to be the ancestor to the domestic horse, the Przewalski’s horse is 
the only remaining wild horse in existence today (Groves, 1994).
The first visual account of the existence of wild type similar to Przewalski’s horses
was 20,000 years ago.  Cave drawings in Italy, western France and northern Spain 
depicted small horses with upright manes, similar to the Asian Wild Horse (Bouman and 
Bouman, 1994).  After the last ice age around 10,000 BC, the steppes in Europe changed 
to forests and many of the wild horses moved east (Azzaroli, 1966).  It was not until 900 
AD that the first written account of the Asian Wild Horse occurred in Tibet (Zevegmid
and Dawaa, 1973).  In 1226, while on a campaign against Tangut, Genghis Khan spotted 
a herd of wild horses which resulted in his horse getting spooked (B k nyi, 1974).  The 
first western account of the Asian Wild Horse was in 1719, when John Bell, a doctor 
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working under Czar Peter the Great, described wild horses in an account of his travels 
from St. Petersburg to China (Mohr, 1971).
In 1878, Colonel Nikolai Przewalski, a Polish explorer under Czar Alexander II, 
received a horse skull and hide as a gift during his travels in China (Bouman and 
Bouman, 1994).  On his return to Russia, the conservator of the Zoological Museum of 
the Academy of Science, I.S. Poliakov, concluded that the hide and skull belonged to a 
wild horse.  As a result, the Asian Wild Horse was given the official name Equus 
przewalskii (Bouman and Bouman, 1994).
At the time of their discovery in the late 1800s, horses were distributed throughout 
the entire Eurasian steppe belt, which extends from Hungary to Mongolia and the 
northeastern margins of China (Bouman and Bouman, 1994; Garrutt et al., 1965).
Unfortunately, by 1958, the population range had severely contracted to the Dzungarian 
Gobi in Mongolia (Mohr, 1971). In 1969, the last sighting of a Przewalski’s horse 
occurred north of the Tachjin-Shar-Nuru (Paklina and Pozdnyakova, 1989).
Species on the Brink
Hunting by nomads, competition with domestic livestock and harsh weather resulted 
in rapid decline in the numbers of the Przewalski’s horse during the 20
th
century (Paklina
and Pozdnyakova, 1989), and the species was declared extinct in nature in 1969. The 
current captive Przewalski’s horse population in North America is derived from 14 founders 
that were captured in the wild during the 1900s (Ryder, 1994; Monfort et al., 2009).
Starting in the 1980s, re-introduction sites were established in China, Mongolia and 
Kazakhstahn (Boyd et al., 2008).  Zoological institutions from Europe, North America 
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Figure 1.1: Demographics of current SSP population.  Blue represents actual population.  
Red indicates a stable population (Monfort et al., 2009).
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and Australia contributed animals to re-introduction sites and there are currently over 500 
animals living in their native habitat.  As a result, the International Union for the 
Conservation of Nature (IUCN) changed the status of the Przewalski’s horse from ‘Extinct 
in Wild’ to ‘Critically Endangered’ (Boyd et al., 2008).  To ensure the maintenance of a 
genetically healthy reservoir population, approximately 500 Przewalski’s horses are 
managed by zoos in the USA and in Europe.  Although reproduction in captive populations 
has been guided by mean kinship values, imperfect captive breeding management has 
resulted in inbreeding, loss of genetic diversity and reproductive capacity, and decreased 
fertility and fecundity (Monfort et al., 2009).  In 2004, the Association of Zoos and 
Aquarium’s (AZA) Species Survival Plan (SSP) for the Przewalski’s horse determined that 
the demography of this regional population (Fig. 1.1) was unstable due to an age structure 
skewed towards older horses (Monfort et al., 2009).  To alleviate this trend, urgent priority 
was given to organizing breeding pairs to initiate a coordinated research program and to 
make animals available for reproductive research.  AZA institutions agreed to contribute 
facilities, and the SSP invited the Smithsonian’s National Zoo’s Department of 
Reproductive Sciences to lead studies in the evaluation of assisted reproductive technologies 
(ART) as a means to better manage the genetic diversity and demography of the 
Przewalski’s horse population.
Artificial Insemination in the Domestic Horse
Artificial insemination (AI) has been used successfully in many domestic species 
for over seventy-five years (Vishwanath, 2003).  In cattle, sheep and goats it is used for 
the improvement of genetics in herds.  In the horse (Equus caballus), AI offers many 
5
advantages over natural mating, including: 1) more efficient use of valuable semen 
samples by allowing allocation of a single ejaculate into several insemination doses; 2) 
augmenting the number of offspring produced per stallion during each breeding season; 
3) increasing availability of stallion semen; 4) decreasing venereal transmission of 
disease to mares due to use of antibiotics in semen extender; 5) reducing breeding injuries 
that occur with natural breeding; and 6) assessing semen quality prior to insemination, 
which assists in early detection of possible fertility problems (Blanchard et al., 2004).  
Also, frozen-thawed semen allows for the production of offspring from a stallion post-
mortem (Brinsko and Varner, 1992).  
The success of AI in the domestic horse, however, relies heavily on a heightened 
knowledge of reproductive physiology of mares and stallions.  Furthermore, because 
spermatozoa are very susceptible to environmental injury, proper semen collection, 
handling, processing, and insemination are necessary to produce higher pregnancy rates 
(Blanchard et al.,2004).  For example, stallion spermatozoa are extremely sensitive to 
cold shock, therefore all equipment used for handling or processing sperm should be at 
37° C (Brinsko and Varner, 1992; Loomis and Graham, 2008).  Spermatozoa should also 
be placed in a suitable semen extender to maintain viability.  Properly formulated semen 
extenders for the stallion are milk and egg based with added sugars and antibiotics 
(Blanchard et al., 2004).
In addition to semen handling techniques, mare management is equally important 
for achieving pregnancy following AI. Successful AI (75% pregnancy rate) generally 
requires mares to be inseminated with 250 – 500 million progressively motile frozen or 
chilled semen (Brinsko and Varner, 1992; Fiala et al., 2007) once during the 48-hours 
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interval preceding ovulation (Woods et al., 1990).  Overall, when proper semen handling 
and insemination techniques are used, optimal pregnancy rates are attainable, even in 
mares and stallions with marginal fertility (Blanchard et al., 2004; Crowe et al., 2008).
The Application of Artificial Insemination in Wildlife
There are several reasons why AI has tremendous potential for application to
wildlife species, including:  1) overcoming incompatibility between designated breeding 
pairs; 2) decreasing the need to hold males at institutions only for breeding purposes; 3) 
preserving genetic diversity in captive populations; and 4) reducing risks associated with
moving animals from one zoological institution to another for the purpose of natural 
breeding (Pukazhenthi and Wildt, 2004).  AI has been used successfully in several 
wildlife species, for example, the giant panda (Alluropoda melanoleuca; Huang et al., 
2002), African (Loxodonta Africana) and Asian elephants (Elephas maximus; Hermes et 
al., 2007; Thongtip et al., 2009), Eld’s deer (Cervus elddi; Monfort et al., 1993), 
scimitar-horned oryx (Oryx dammah; Morrow et al., 2000) and black footed ferrets 
(Mustela nigripes; Howard et al., 2003).  Similar to the Przewalski’s horse, these species 
either have rapidly decreasing numbers of or no new founders in the wild.
Reproductive research in Przewalski’s horses is especially important because the 
North American population is comprised mostly of older animals  that are greater than 10 
yr old (96/149 horses total; 66% of mares and 53% of stallions; Spevak and Monfort, 
2004; Powell, 2009).  Decreased fertility in domestic horses greater than 10 yr old has 
dictated more intensive breeding management in these animals, and ARTs, such as
artificial insemination and embryo transfer, have been used to overcome these difficulties 
7
(Samper, 2000, van Buriten et al., 2003).  However, success requires a detailed 
understanding of the reproductive biology of Przewalski’s mares and stallions, as well as 
developing optimal collection protocols and technologies for semen collection, 
cryopreservation, and AI.                                                                                                    
Limited research has been conducted on the Przewalski’s mare to establish temporal 
follicular (Durrant and Hoge, 1988; Durrant et al., 1986) and endocrine patterns through 
milk (Zimmermann, 1985), urine (Monfort et al., 1991), and fecal (Schwarzenberger et al.,
1992) steroid monitoring.  Furthermore, only a small number of reports have described 
ejaculate characteristics in this species (Stover et al., 1981; Durrant, 1990; Bader et al., 
1991). The Przewalski’s horse is a flagship species that simply would not exist today 
without the contribution made by the international zoo community.  However, nearly 30% 
of the genetic variation present in the original 14 founders has already been lost due to 
suboptimal reproductive management (Spevak and Monfort, 2004).  Zoos face a daunting 
challenge: a century’s long obligation to maintain genetically viable reservoir populations, 
including genome resource banks (GRBs) that will help to insure the survival of 
Przewalski’s horses.  This responsibility will remain even after the full complement of 
founder-based genetic diversity is represented in self-sustaining wild populations - an
equilibrium that has yet to be achieved for this species.  
Reproduction in Przewalski’s Mares
Limited research has been conducted on reproductive physiology of Przewalski’s 
mares.  Behavioral research has shown that mares cycle in the spring and summer, and 
produce foals 11-12 months after breeding similar to their domestic counterparts
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(Monfort et al., 1991; Houpt and Boyd, 1994).  Estrous cycle patterns have also been 
determined by assessing follicular structures using rectal ultrasonography (Durrant et al., 
1986) or by assessing hormone metabolites in milk (Zimmermann, 1985), urine (Monfort
et al., 1991) and feces (Schwarzenberger et al., 1992).
Two mares that were examined seven times over a three month period exhibited 
follicular characteristics that were similar to the domestic mare (Durrant et al., 1986).  
Each mare was examined under anesthesia using a linear array ultrasound and follicular 
size was noted as well as other structures.  Follicles grew 3 – 5 mm per day and ovulated 
when they reached a diameter of 48 – 50 mm.  While information on follicular changes 
was established, no data on hormonal changes or estrous cycle length were reported.
The most extensive longitudinal study of reproductive endocrinology in 
Przewalski’s mares utilized non-invasive hormone monitoring in eight individuals over 
the period of 18 months (Monfort et al., 1991).  Analysis of estrogen metabolites using 
radioimmunoassay (RIA) revealed that the onset of hormonal activity occurred with 
increasing day length (from February through April), but that most mares did not 
conceive until after March (Monfort et al., 1991), indicating the possibility that mares 
have a transitional period of hormonal activity prior to actual follicular development,
which is similar to what is observed in the domestic horse (Ginther, 1992). It was also 
determined that estrous cycle length was about 24 days based on average length between 
urinary estrogen peaks.   However, this study only looked at urinary estrogens in relation 
to estrous behavior and pregnancy.
An earlier study that analyzed progesterone metabolites in milk secretions from two 
post-partum mares revealed that milk progesterone levels increased and decreased 8 and 
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35 days post-ovulation, respectively, implying that progesterone is secreted post-
ovulation (Zimmermann, 1985).  Findings from this study suggest that, similar to most 
species, progesterone is important in maintenance of early pregnancy.  In a subsequent 
study, fecal progestagen excretion revealed cyclical patterns in 3 of 4 non-pregnant 
Przewalski’s mares (Schwarzenberger et al., 1992).  Although no study has yet defined 
the temporal patterns of progesterone excretion during pregnancy, it has been presumed 
that Przewalski’s mares, like other mammalian species, require corpus luteum (CL)-
derived progesterone to sustain early pregnancy.
Reproduction in the Domestic Mare
Seasonality
The domestic mare is considered a long day breeder with cycles occurring in spring 
and summer (Northern Hemisphere: April – August; Southern Hemisphere: September –
February). Similar to other seasonal breeders, photoperiod is the main factor driving 
seasonality in the domestic mare (Ginther, 1993; Blanchard et al., 2004). Increases in 
day length trigger a decrease in melatonin secretion from the pineal gland, that in turn,
causes an increase in gonadotropin releasing hormone (GnRH), which leads to 
resumption of cyclicity in late spring in most mares (Ginther, 1993).
In addition to increasing day length, opioids, a family of peptides secreted in the 
brain, may also participate in the regulation of seasonal reproduction by modulating 
luteinizing hormone (LH) secretion during winter anestrus (Turner et al., 1995). Opioid 
levels were higher in mares during deep winter anestrus than during the breeding season,
however, the use of opioid antagonists (naloxone) in mares did not alter onset of 
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reproductive activity in anestrous mares (Turner et al., 1995). Specifically, anestrus 
mares treated with naloxone showed no significant increase in estrous activity compared 
to untreated mares.  
More recent research also has shown that other factors such as body condition score 
(BCS) can have an impact on reproductive seasonality in mares (Waller et al., 2006; 
Gentry et al., 2002; Vecchi et al., 2010).  For example, mares with a BCS of 7.5 – 8.5
(out of 9) continued to ovulate or have follicular activity through the winter compared to 
mares of low BCS (3.0 – 3.5) (Gentry et al., 2002). Similarly, Vecchi et al. (2010) 
showed that Standard bred mares in poor body condition and reduced adipose tissues 
were slower to return to estrus after winter anestrus than those with good body condition.
Leptin is an adipocyte-derived hormone that acts in some species to signal the brain 
regarding the body’s nutritional status (Houseknecht et al., 1998).  In rodents, females 
lacking sufficient leptin display reduced gonadotrophin release, anestrus, or both (Barrash
et al., 1996; Carro et al., 1997).  In the horse, mature mares (6 – 12 years) showed higher 
leptin levels compared to younger individuals (2 – 5 years), suggesting that this peptide 
hormone may play an important role in regulating the reproductive cycle in this species 
(Fitzgerald and McManus, 2000).  However, more recent studies, have shown that leptin 
is not consistently elevated in mares that cycle year round and that other metabolic 
factors may be confounding the length and depth of anestrus in mares (Gentry et al., 
2002; Waller et al., 2006).
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The Estrous Cycle of the Domestic Mare
In the domestic mare, the estrous cycle is defined as the period from one ovulation 
to the subsequent ovulation.  The two periods of the estrous cycle in the mare are: 1) the 
follicular phase (estrus) – the mare is sexually receptive to the stallion and a dominant 
follicle is present on the ovary; and 2) the luteal phase (diestrus) – the mare is non-
receptive to the stallion, and one or more corpora lutea are present on the ovary (Figure 
1.2; Blanchard et al., 2003).  The average length of the estrous cycle ranges from 18 – 24
days (average 21 – 22 days).  Length of estrus is variable (2 -12 days) based on time of 
year.  It is believed that this variation could be due to a less prominent LH surge early in 
the breeding season (Palmer, 1978; Ginther, 1992).  The length of diestrus remains 
relatively constant at 14 – 15 days and is less affected by season than length of estrus 
(Blanchard et al., 2004). 
Mares have one or two major follicular waves during the estrous cycle (Ginther, 
1992).  A major wave is defined by the emergence of several follicles that grow in 
synchrony until a dominant follicle is selected and subordinate follicles regress.  In mares 
that have two waves during the interovulatory interval, the wave that first emerges is the 
secondary wave (Ginther, 1992).  Emergence of this secondary wave occurs in late estrus 
or early diestrus and may result in an ovulation during diestrus or regression of the 
dominant follicle.  The wave that results in ovulation during estrus is the primary wave, 
and emerges during late diestrus (Figure 1.3; Ginther, 1992).  
The estrous cycle of the mare relies on a delicate balance of hormones produced by 
the pineal gland, hypothalamus, pituitary gland ovaries and the uterus (Figure 1.4).  The 
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Figure 1.2:  The estrous cycle of the domestic mare (Blanchard et al., 2003).  
neurosecretory cells of the hypothalamus produce GnRH, which is episodically released 
into the hypothalamo-pituitary portal system and stimulates the anterior pituitary to 
produce the gonadotrophins, follicle stimulating hormone (FSH) and LH (Blanchard, 
2004).  FSH and LH act at the level of the ovaries: FSH is responsible for follicular 
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Figure 1.3: Follicular wave patterns in the domestic mare (Ginther, 1992).
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Figure 1.4: Hypothalamo-pituitary-gonadal axis in the domestic mare 
(Blanchard et al., 2003).
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recruitment and LH is responsible for follicular maturation, estrogen production, 
ovulation, and luteinization of the corpus luteum (Ginther, 1992; Senger, 2003). 
The mare, similar to most species, has a follicular pool at birth.  Antral follicles are 
recruited from the pool under the influence of LH and FSH released from the anterior 
pituitary.  LH binds to theca interna cells of antral follicles, which stimulates the 
production of testosterone.  FSH then binds to granulosa cells of the follicle causing the 
conversion of testosterone to estradiol (Ginther 1992; Ojeda, 2004).  Increasing estradiol 
stimulates granulosa cell proliferation, which increases follicle sensitivity to 
gonadotrophins.  As the follicles continue to grow, more estrogen is produced, which in 
turn causes negative feedback to the anterior pituitary and suppresses FSH secretion, but 
induces an increase in LH secretion. Once follicle selection has occurred, the largest 
follicle produces more estrogen and inhibin, which further suppresses FSH and leads to 
the regression of smaller follicles (Senger, 2003).  Rising estrogen triggers the 
preovulatory surge in LH, which induces a cascade of cellular events that result in 
ovulation.  The specific endocrine and biochemical mechanisms involved in ovulation in 
the domestic horse are still unknown, but is assumed to be similar to other species 
whereby LH (via binding to theca interna cells), cyclic AMP, prostaglandins and steroids 
play a vital role in modulating a complex series of biochemical reactions leading to the 
preovulatory changes within the follicular wall that precede ovulation (Ginther, 1992; 
Senger, 2003; Ojeda, 2004).
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The mare is unique compared to other domestic animals in that the preovulatory rise 
in LH occurs over several days and often reaches its peak 1- 2 days after ovulation of the 
dominant follicle (Palmer, 1978; Blanchard et al., 2003).  Follicular diameter at ovulation 
ranges from 30 – 70 mm (average 40 – 45 mm).  After ovulation, theca interna and 
granulosa cells luteinize under the influence of LH, and turn into luteal cells (Senger 
2003).  The luteal cells develop into a CL on the ovary and secrete progesterone 
throughout the period of diestrus, which normally lasts 14 - 15 days (Blanchard et al., 
2003). The presence of tonic LH and cholesterol is required for progesterone to be 
produced by luteal cells via the steroidogenic pathway (Senger, 2003; Ojeda, 2004).  
Progesterone is important in that it provides negative feedback to the hypothalamus, 
reducing the episodic secretion of GnRH while a functioning CL is present on the ovary 
(Senger, 2003).
The life span of the CL in the horse is maintained until an endogenous release of 
prostaglandin F!" (PGF!") from the uterine endometrium that normally occurs between 
day 13 – 16 post-ovulation (Ginther, 1992; Senger, 2003; Blanchard et al., 2004).  
Similar to other species, progesterone, estrogens and oxytocin control the release of 
PGF!" from the endometrium (Ginther, 1992).  However, the horse is different in that 
PGF!" enters the systemic circulation after release from the uterus, rather than through a 
local countercurrent system as seen in ruminants (Ginther, 1992; Senger, 2003).  This is 
because the mare does not metabolize PGF!" as quickly as other species, and it is 
believed that the mare also is more sensitive to lower levels of prostaglandins compared 
to other species (Senger, 2003).  PGF!" binds to receptors on the plasma membrane of 
luteal cells and causes the activation of protein kinase-C, which inhibits progesterone 
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synthesis (Senger, 2003).  Prolonged diestrus in the mare is often caused by failure of 
luteolytic mechanisms which results in continued progesterone production from the CL.
Steroidogenic Pathway
Steroids are a subclass of lipids that contain a basic structure of four fused rings 
referred to as perhydroxylopentanophenanthrene (Ojeda, 2004).  All steroids are formed 
by the polymerization of an active isoprene unit, which is derived from acetyl CoA.  
Polymerization of six activated isoprene units results in cholesterol (Figure 1.5), which is 
the initial precursor for steroid biosynthesis (Ojeda, 2004).  The regulatory step of steroid 
hormone production is the conversion of cholesterol (27 carbons) to pregnenalone (21 
carbons), which involves two hydroxylations.  Cytochrome P450 initiates this reaction, 
which occurs in the mitochondria of steroidogenic cells that are located in ovaries, testes, 
adrenal cortex, placenta and brain.  Pregnenalone and progesterone represent the 
precursors for all hormonally active steroids (Figure 6).  The type and amount of steroids 
being produced depends on the physiologic nature of the cell and the activity of the 
enzyme systems (Ojeda, 2004).  For example, the testes and ovaries are able to produce 
all hormones shown in diagram 2, but the production of estrogens and 
dihydrotestosterone (DHT) by the testis is limited, whereas the production of DHT by the 





Steroid biosynthesis in the ovary
The ovary produces steroid hormones that are important for reproductive functions
(Ojeda, 2004).  The main steroids produced by the ovary are progesterone and estradiol 
(Figure 1.6).  Estradiol is produced mainly by granulosa cells of the follicle, whereas 
progesterone is secreted by all steroidogenic cells of the ovary (Ojeda, 2004). The ovary 
also produces androgens, such as androstenedione and testosterone, but a significant 
portion of these hormones is converted into estrone or estradiol (Ojeda, 2004). 
Cholesterol, which is derived from dietary animal fats or from local de novo 
synthesis, provides the carbon backbone for steroidogenesis (Ojeda, 2004).  Low-density 
lipoproteins (LDLs) transport cholesterol and bind to membrane receptors on cells 
causing the LDL complex to enter the cell by endocytosis (O’Malley et al., 1991). 
Subsequently, cholesterol is transported into the mitochondria by Steroidogenic Acute 
Regulatory protein (StAR), which promotes the transfer of cholesterol from the outer to 
the inner mitochondrial membrane (Ojeda, 2004).  Cholesterol, which has 27 carbons, is 
then converted to pregnenalone (21 carbons) by the mitochondrial enzyme cholesterol 
side chain cleavage (Ojeda, 2004).  Pregnenalone is then converted to either progesterone 
or 17 - hydroxypregnenalone, both of which are transformed to 17 -
hydroxyprogesterone. Androgens, estrogens and progestagen are derived from hydroxy-
progesterone, which is converted to androstenedione, and then further reduced to either 
an androgen (19 carbons) or an estrogen (19 carbons) (Ojeda, 2004).  Cleavage of 17 -
hydroxyprogesterone by the enzyme 17, 20 lyase yields androstenedione, an androgen 
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Figure 1.6: Steroidogenic Pathway (Ojeda, 2004)
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Figure 1.7: Two-cell – two gonadotrophin theory.  LH acts on thecal cells to 
produce testosterone; FSH acts on granulosa cells to produce estradiol (Ojeda, 
2004).
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Testosterone is then converted to estradiol by an aromatase enzyme (Ojeda, 2004).  
For androgen and estrogen production to occur, ovarian granulosa and theca cells must 
work in tandem (O’Malley et al.,1991), which builds the basis of the two cell – two 
gonadotrophin theory (Figure 1.7). According to theory, LH dependent androgens 
derived from theca cells are converted to estrogen in the granulosa cells by FSH-
inducible aromatase activity (O’Malley et al., 1991).  Studies of isolated granulosa cells 
revealed that only FSH stimulates estrogen synthesis (O’Malley et al., 1991; Ojeda, 
2004).  In contrast, isolated theca cells did not produce significant amounts of estrogens, 
which supports the concept that granulosa cells are the principal site of estrogen 
production (O’Malley et al., 1991).  
Progesterone is produced by large luteal cells of the CL under the influence of LH 
(Figure 8; Senger, 2003).  Esterified cholesterol forms a complex with LDL to facilitate 
delivery and binding to target cells. When LH binds with luteal cell surface receptors 
protein kinase C is activated this internalizes the cholesterol-LDL complex.  Protein 
kinase also promotes entry of cholesterol into the mitochondria where it is converted to 
pregnenalone (Senger, 2003).  Pregnenalone is then converted to progesterone, which 
enters the blood circulation and modulates GnRH production at the level of the 
hypothalamic-pituitary axis. 
Reproduction in Przewalski’s Stallions
Similar to the Przewalski’s mare, there is very little known about the reproductive 
physiology of Przewalski’s stallions.  To date, there are no studies assessing endocrine 
rhythms and only a few reports that have described semen characteristics.  Most studies 
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that have assessed semen characteristics were on anesthetized males using electro –
ejaculation as the means for collection (Bader et al., 1991; Durrant, 1990; Stover et al., 
1981) and most of these examined limited numbers of stallions.  A study by Durrant 
(1990) showed that there were seasonal changes in semen parameters over a one-year 
period in five stallions.  To date, no longitudinal studies have systematically assessed 
seminal parameters in the Przewalski’s stallion. 
Reproduction in the Domestic Stallion
Seasonality
Like the domestic mare, the stallion has been considered a ‘long - day’ breeder.  
Ejaculate volume, total sperm concentration, libido, testicular size, and plasma 
concentrations of steroid and protein hormones increase in summer months compared to
winter months (Roser, 2008).  However, it is important to note that stallions produce 
sperm throughout the year.  The endocrine events that initiate an increase in testicular 
activity have not been characterized but appear to be based on photoperiods (Blanchard et 
al., 2004).  Similar to the domestic mare, longer day lengths cause decreased production 
of melatonin from the pineal gland, increased GnRH secretion from the hypothalamus, 
which in turn, stimulates spermatogenesis. In stallions, the shorter days of autumn are 
important to the photoperiod-induced increase in sperm production observed during the 
spring. Normally, increased day length would induce an increase in testicular size.  
However, stallions maintained on long days (i.e., 16 hours of light/day) for a 15-month 
period experienced testicular regression, demonstrating refractoriness to photoperiod 
(Clay and Clay, 1992).  Based on these results, the decrease in day length in the autumn 
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may provide a critical trigger in resensitizing the stallion to the photoperiod of long days 
(Roser, 2008).
Spermatogenesis
Spermatogenesis is the sum of cell divisions and cellular changes that result in formation 
of spermatozoa from spermatogonia (Amann et al., 1993).  The entire process occurs in 
the seminiferous tubules, which comprises most of the testicular parenchyma in the 
stallion (Meyers, 2000).  Sertoli cells comprise the myoid cell layer and, although their 
role in spermatogenesis is still not fully understood, probable functions include: 1)
formation of the blood – testis barrier; 2) structural and nutritional support for the
germinal cells, 3) facilitation of the movement of developing germinal cells within the 
seminiferous epithelium; 4) release of mature spermatozoa by a process of spermiation; 
and 5) cell-to-cell communication with developing germinal cells and Leydig cells 
(Amann et al., 1993; Meyers, 2000).  Leydig cells are located in the interstitial 
compartment and are critical to spermatogenesis due to their steroidogenic capabilities.
In the stallion, GnRH controls spermatogenesis through the production of FSH and 
LH from the anterior pituitary (Figure 1.8; Griffin, 2004).  LH binds to Leydig cells and 
converts cholesterol to testosterone.  Testosterone is then transported to Sertoli cells
where it is converted to dihydrotestosterone and estradiol under the influence of FSH 
(Senger, 2003).  Inhibin is also produced by Sertoli cells and is believed to modulate FSH 
production through negative feedback on the anterior pituitary (Griffin, 2004).  The role 
of estradiol in male reproduction is still not understood but is believed to also play a role 
in negative feedback of FSH (Senger, 2003).
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Figure 1.8:  Endocrine control of spermatogenesis.  T = Testosterone; C = 
Cholesterol (Griffin, 2004).
26
Spermatogenesis is comprised of three phases: 1) spermatocytogenesis, 2) meiosis, 
and 3) spermiogenesis (Meyers, 2000).  The entire process takes 57 days in the domestic 
stallion (Amann et al., 1993).  The process starts with spermatogonia (Type A1), haploid 
cells, which are the most primitive cells in spermatogenesis, located at the basal 
compartment of the seminiferous tubules (Senger, 2003).  These cells divide to produce 
diploid cells that will either complete spermatogenesis or repopulate the stem cell 
population.  The A1 spermatogonia mitotically divide at regular intervals to enter the 
spermatogenic cycle and differentiate into at least five subtypes – A1 - 3, B1, B2 (Meyers, 
2003).  The B2 spermatocytes then enter the second stage of spermatogenesis by 
initiating meiosis as primary spermatocytes.  After the first division of meiosis the 
primary spermatocyte becomes a secondary spermatocyte, which rapidly progresses to 
the haploid spermatid (Senger, 2003).  The spermatid has an elongated shape, condensed 
nucleus and axoneme that are the characteristics of a sperm cell (Meyers, 2003).  During 
maturation, mitochondria form the midpiece around the flagellum of the sperm and the 
postnuclear cap is formed (Senger, 2003). Once cells have reached this stage, spermiation 
occurs, which is a synchronous release of all spermatozoa into the seminiferous tubule 
and the epididymis for the final sperm maturation. Spermatozoa are continuously released 
into the seminiferous tubules throughout reproductive life in a male.
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Assisted Reproduction in the Domestic Horse
Assisted reproductive technologies, especially AI, are tools commonly used for 
breeding management in the domestic mare.  Historically, studies on the collection, 
processing and insemination with stallion semen were initiated in the late 1800s in 
Russia.  However, this technology was not used in the United States until the 1940s 
(Samper, 2000; Blanchard et al., 2003).  Since many breed registries now allow AI for 
the production of foals, this method has been increasingly utilized during the past decade.
Artificial insemination in the domestic horse involves collection, dilution and 
preservation of stallion sperm, as well as timely placement of an adequate number of 
sperm cells in the mare’s uterus (Samper, 2000).
Semen Collection and Preservation
The most convenient method of semen collection is by use of the artificial vagina 
(AV).  Although there are many different designs, all AVs work on the same principle, 
which utilizes a double rubber liner with warm water between the layers to provide  
appropriate temperature conditions (Samper, 2000).  Stallions produce an ejaculate 
following proper stimulation that closely resembles natural breeding. The disadvantage 
of this technique is that stallions require training to mount a dummy phantom mare and 
also to adapt to collection with an AV (Blanchard et al., 2003).  Unskilled handlers can 
also be injured during the collection process. 
More recently, another method of semen collection in the domestic stallion was 
developed using imipramine and alpha-2 agonists (xylazine or detomidine) that induce 
ejaculation in a standing stallion (McDonnell and Odian, 1994; Card et al., 1997). While 
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the mechanism is not well understood, it is believed that imipramine lowers the 
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In the domestic stallion, if semen is used for AI within 12 hours after collection, it 
can be stored at room temperature in the dark, but if semen is used 12 - 72 hours post-
ejaculation, then semen should be extended and chilled to 4ºC (Samper, 2000).  Most 
semen extenders used in the domestic stallion are milk-based products that contain 
antibiotics (Blanchard et al., 2003). Some examples of common extenders are: Kenney 
extender (nonfat dry milk solids, glucose, penicillin, streptomycin and gentamicin); 
TAMU formula (nonfat milk solids, glucose, sucrose, penicillin, and amikacin); and 
VMD-Z
agonist induces ejaculation.  This method requires a 
lengthy titration of drug combinations for individual stallions to effect and is less reliable 
than AV.  For stallions that are not trained to collection by AV, condoms have also been 
used for the purpose of semen evaluation, but are rarely used for semen preservation due 
to the poor semen quality caused by bacterial contamination derived from the external 
sheath of the penis (Blanchard et al., 2003).  Electro-ejaculation under general anesthesia 
has also been attempted with limited success in the domestic stallion (Cary et al., 2004).
TM
More recently, the use of frozen semen has grown in popularity because this 
technology allows transportation of samples obtained from genetically-valuable stallions 
throughout the world.  The first foal born using frozen – thawed sperm was in 1957 
(Samper, 2000).  To date, fertility rates of mares inseminated with fresh-cooled sperm are 
comparable to natural breeding (60 – 70%, Samper, Vidament, 2005), whereas foaling 
Formula (egg-based extender with amikacin and penicillin) (Brinsko and 
Varner, 1992; Aurich, 2008). When semen is extended and properly stored, sperm cells
usually are viable for up to 72 hours.  
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rates are much lower in mares inseminated with frozen-thawed sperm (30 – 65%, 
Vidament, 2005; Samper and Plough, 2010). There are large variations in the quality of 
frozen-thawed sperm among stallions.  Specifically, spermatozoa from approximately 25
percent of stallions do not survive the freezing and thawing process (Graham, 1996; 
Adams et al., 2009).
Manipulation of the Estrous Cycle
Treatments aimed at synchronizing or manipulation the estrous cycle are used for 
management of many domestic and wildlife species for the purpose of fixed time AI, 
managing birth dates and for the synchronization of recipients in embryo transfer. It is 
commonly used in cattle, pigs, sheep, and white tailed deer.  It has also been used in 
wildlife species, such as the scimitar horned oryx (Oryx dammah; Morrow et al., 2000),
Eld’s deer (Cervus eldii; Monfort et al., 1993) and killer whale (Orcinus orca; Robeck et 
al., 2004).  Ovarian synchronization schemes have benefited from an improved
understanding of the endocrine system and the ability to objectively assess the success or 
failure of various regimens.  In practice, however, factors such as cost, labor, time of year 
and personal preference have a strong influence on the methods chosen (Bergfelt, 2000).  
Most estrous synchronization systems utilize methods that control follicular wave 
development, which results in estrus and ovulation (Lucy et al., 2004).  Hormones used 
to pharmacologically control the estrous cycle have similar effects on the endogenous 
reproductive hormones found within the hypothalamus (gonadotrophins), ovary (estradiol 
and progesterone) and uterus (prostaglandins) (Bergfelt, 2000; Lucy et al., 2004)
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Methods Used in the Domestic Horse
The extended estrus period in the mare, with ovulation occurring 1 – 10 days after 
the beginning of behavioral estrus, complicates reproductive management.  Various 
combinations of reproductive steroids (progestagens and estrogens), PGF2 , human 
chorionic gonadotropin and GnRH agonists have been used to control follicular 
development and ovulation in domestic mares (Taylor et al., 1982; Blanchard et al., 
2003).  Despite much research in the area, reliable estrous synchronization of domestic 
mares remains challenging and research is - ongoing to determine the optimal method for 
this species (Bergfelt, 2000; Bergfelt et al., 2007)
Prostaglandins:
Most synchronization methods in the domestic mare modify the luteal phase of the 
estrous cycle (Blanchard et al., 2003).  The administration of PGF!" causes luteolysis of 
the CL in the domestic mare (Douglas and Ginther, 1972; Noden et al., 1974).  However, 
this treatment has low efficacy (52%; Burns et al., 1979) and there is wide variation in 
the interval from when treatment is initiated to the subsequent ovulation.  This variation 
relates, in part, to the stage of the reproductive cycle and follicular development at the 
time of hormone administration.  Specifically, the CL is refractory to PGF!"-treatment
until 5 days post-ovulation (Bristol, 1993).  Also, if PGF!" is administered more than 9 
days post-ovulation the interovulatory interval will not be shortened (Blanchard et al., 
2003) due to release of endogenous prostaglandins.  To increase estrous synchrony using 
PGF!", two injections were given 14 days apart to 33 mares (Burns et al., 1979).  After 
the second injection, 26 (79%) of mares showed estrus within 4.4 ± 1.7 days and 31 
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(94%) ovulated in 7.2 ± 2.6 days (range: 2 – 10 days; Burns et al., 1979).  In further 
attempts to reduce variability associated with this two-shot PGF!"-protocol, human 
chorionic gonadotropin (hCG) was administered 4 – 6 days after the second PGF!"
injection (Palmer, 1975; Allen, 1976; Bosu et al., 1983).  While these studies showed 
improved synchrony, other studies showed varied response based on time of year 
(Squires, 1981; Holtan et al., 1977).  In one trial, two prostaglandin injections were given 
18 days apart in pony mares from June to August.  Six days after the second 
prostaglandin injection, hCG was administered and only 26.1 % of mares (6 of 23) 
ovulated within 48 hours of hCG (Holtan et al., 1977)
Progestagens:
Progesterone treatment, which is intended to mimic the suppressive effects of 
endogeneous hormone on the hypothalamic-pitutiary axis, must be administered long 
enough to permit regression of any extant CL.  Thus, exogenous progestagen treatment 
must typically last 12 – 18 days in the mare (Bristol, 1993, Bergfelt, 2000).  Exogenous 
progestagen treatment, such as the use of oral altrenogest, is commonly used in the 
domestic mare to suppress endogenous LH secretion and ovulation (Bergfelt, 2000).  
Progestagen treatment alone has little, if any, effect on FSH secretion.  This results in a 
large amount of variation in follicular growth during the treatment interval, which results 
in high variation in the degree of ovarian synchrony among females (Bergfelt, 2000).  For 
example, 15 mares that were given oral altrenogest (0.044 mg/kg/day for 15 days) 
showed estrus 3.4 ± 1.9 days and ovulated 8.8 ± 2.2 days after treatment (Squires et al., 
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1983).  This degree of variation means that mares ovulated anywhere from 8 – 15 days 
post-treatment.
To improve synchrony, PGF2 treatment at the end of progestagen treatment has 
been used to ensure regression of a primary or secondary CL. However, an 8-day 
treatment with altrenogest combined with PGF2 administered on day 8 resulted in mares 
ovulating 8 – 15 days post treatment (Palmer, 1975).  What is especially challenging is 
that while the degree of estrous synchrony can be relatively high using the 
progestagen/PGF2 regimen, ovulation synchrony is poor (Lofstedt and Patel, 1989; 
Bergfelt, 2000).  Because treatment with progestagens does not prevent follicular 
development and ovulation from occurring during treatment, PGF2 
Recently, an injectable form of altrenogest (Biorelease altrenogest; Betpharm, 
Lexington, KY, USA) has been developed (Burns et al., 2008).  The use of this product 
has improved estrous suppression compared to the oral form (Burns et al., 2006).
Injectable altrenogest releases hormone into the circulation over a 10 to 12-day period in 
domestic mares and has been shown to be effective at inhibiting production of 
progesterone.  To date, limited research has been conducted to compare the injectable to 
may be only 
partially effective for inducing luteolysis (i.e., some younger CL would be refractory to 
treatment), and this has a detrimental effect on achieving ovarian synchrony (Bristol, 
1993).  Because follicular development is not fully inhibited by treatment with 
progestagens, a wide variation in follicular development – and hence the hormonal milieu 
– exists after termination of treatment (Lofstedt and Patel, 1989; Blanchard et al., 2003).  
This results in a wide variation of intervals to ovulation in domestic mares.  
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the oral form of altrenogest and to assess the use of injectable altrenogest as a method of 
estrus synchronization in the domestic mare.
Progestagens and Estrogens:
The hormonal regimen used most commonly in the domestic mare to control both 
follicular development and ovulation is a combination of progesterone plus estradiol 
(P&E).  Typically, the protocol requires daily intramuscular injections of progesterone 
and estradiol for 10 days beginning at any stage of the cycle.  An injection of PGF2 is 
administered on the last day of treatment and an ovulatory agent is given when a follicle 
> 35mm is detected by rectal ultrasound (Bergfelt et al., 2007).  The P&E treatment 
regimen, with or without an ovulatory agent resulted in ovulation in 54 – 68% of mares 
within 2 days of treatment cessation, and in 72 – 94% of mares within 4 days of treatment 
completion (Loy et al., 1981; Taylor et al., 1982). With hCG treatment, ovulations 
occurred within 2 days of treatment completion in 70 – 73 % of mares (Varner et al.,
1988).  In a recent study by Bergfelt et al (2007), 90% of treated mares ovulated within 4 
days of treatment cessation.  Pregnancy rates following progesterone and estradiol, with 
and without hCG, have ranged from 62 to77% (Taylor et al., 1982; Varner et al., 1988).
While the results of progesterone and estradiol are very reliable compared to oral 
treatments, to date, the only method for administering estradiol is through daily 
injections, which is often not practical and may cause physiological stress and/or side 
effects such as anemia and abscess reactions to frequent painful injections (Bergfelt, 
2000).  
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Reasons for Success/ Failure
There are many examples of how extensive research in wildlife reproduction has 
been necessary for the successful use of AI as a genetic tool.  Assisted breeding was first 
attempted in the cheetah in 1980 using AI protocols adapted from cows, with little 
success (Pukazhenthi and Wildt, 2004).  After extensive studies of in situ and ex situ 
populations, which included investigation of the reproductive cycle, time and type of 
ovulation, methods for inducing ovulation and sperm collection and processing methods, 
AI using fresh semen has been successfully applied in cheetah (Acinonyx jubatus;
Howard et al.,1997).
The black footed ferret (Mustela nigripes) faced a rapidly declining population in 
the 1960s and 70s.  The current population is based on 18 individuals that were 
discovered in Wyoming in 1981.  Through reproductive research, a successful AI 
technique was developed and 6,000 kits have been produced since research was initiated 
in 1986 (Howard et al, 2003; Comizzoli et al., 2009).  Artificial insemination has also 
been successful in ungulate species such as the scimitar-horned oryx (Oryx dammah; 
Morrow et al., 2000), Eld’s Deer (Cervis eldii; Monfort et al., 1993), and fallow deer 
(Dama dama; Jabbour et al.,1993).
Despite many of these successes, there have also been setbacks.  In many species, 
such as the white rhinoceros (Ceratotherium simum) the Asian and African 
elephant(Loxodonta africanus), it is difficult to collect semen, limiting AI potential in 
these species (Hildebrandt et al., 2000; Brown et al., 2004; Hermes et al., 2007). While 
there is limited research showing that electroejaculation works in Przewalski’s stallions 
(Bader et al.,1991; Durrant, 1990; Stover et al.,1981), there is also evidence that semen 
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collection by electroejaculation does not work reliably in the domestic stallion (Cary et
al.,2004).
Estrus synchronization of females can also present a challenge.  In gazelles (Gazella 
dama), research on synchronization of females resulted in poor results (Holt et al., 1996; 
Pickard et al., 2001).  In the scimitar horned oryx (Oryx dammah), treatment of females 
with CIDRs resulted in a delay in luteal development, whereas treatment with two 
injections of PGF!"-
Because there is limited understanding of reproductive physiology in many species, 
great gaps in knowledge that are necessary to produce pregnancies by AI exists. In the 
Przewalski’s horse, for instance, there are only limited studies on female reproductive 
patterns and seminal characteristics.  To date, there is no data on of ovulation timing or 
estrus synchrony, information which is critical for achieving AI in this species.
resulted in pregnancies (Morrow et al., 2000).  
Therefore, it is necessary to assess reproductive patterns and seminal characteristics 
in Przewalski’s mares and stallions in order for AI to be an effective method of genetic 
management.  The overall goal of this dissertation research was to obtain a more 
comprehensive understanding of the reproductive parameters in the Przewalski’s horse 
for application towards improved species conservation. Specific objectives include: 1)
assessing female reproductive patterns using urinary hormone and follicular data to 
further characterize female estrous patterns; 2) determining whether the estrous cycle can 
be manipulated using exogenous progestagens and gonadotrophins; and 3) describing 
seasonal variation in seminal traits of Przewalski’s stallions.  Before these objectives 
could be accomplished it was first necessary to design a facility that would allow frequent 
ultrasound examination of Przewalski’s mares without sedation or anesthesia. At SCBI, a 
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hydraulic tamer was placed at previously built chute to make manipulation of mares 
simpler.  The chute was actually modified with the addition of extra doors so that 
movement of mares was slower to lower the chance of injury during manipulation.  
Mares were then trained to enter the chute system throughout the year as part of their 
daily routine.  Animal care staff members were also trained in manipulation of the 
hydraulic tamer so that animals were lifted quickly during research periods.  At the 
Wilds, a purpose built facility was already incorporated into the veterinary hospital 
facilities.  As a result, we were able to examine mares 3-times/week without sedation or 
anesthesia.  Frequent observations of follicular changes could be made throughout the 
estrous cycle.  To get an accurate endocrine profile for all mares, urine samples were 
collected 4 – 7 days/week.  Mares were trained to urinate each day through a reward 
system.  Once each mare urinated, they were given a treat (apple biscuit, fruit or carrot).  
As a result, we collected a total of 8,284 urine samples from 22 mares over a 63 month 
period.  After collection, urine samples were frozen at -20° C until analysis was 
complete.  By combining the endocrine and follicular characteristics of mares, we have a 
comprehensive understanding of estrous cycle patterns in Przewalski’s mares.  By 
utilizing these techniques, we also described endocrine and follicular responses to 
hormone therapies that may be used to manipulate the estrous cycle.
Since semen collection in domestic stallions using electro-ejaculation has shown 
poor results, a reliable method of collecting semen from Przewalski’s stallions had to be 
established.  Using techniques that have been established in other wildlife species, we 
were able to develop a semen collection technique that was successful in 84 of 98 semen 
collection attempts from 14 Przewalski’s stallions over a 4 year period.  Thus, we were 
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able to get an accurate description of seminal traits in Przewalski’s stallions due to the 
high number of ejaculates characterized.
Overall, we have a more comprehensive understanding of reproductive patterns in 
Przewalski’s mares and seminal traits in Przewalski’s stallions.  As a result, we have 
determined that there are a high percentage of mares with abnormal reproductive patterns 
that are related to inbreeding.  We have also shown that mares with normal cycles 
respond to exogenous hormone therapy, which could be utilized in breeding management 
of mares.  In stallions, we have determined seasonal patterns in seminal traits and that 
there is a predominant percentage of abnormal spermatozoa in this population, a factor 




Abnormal Reproductive Cycles are Prevalent in Przewalski’s Mares
INTRODUCTION
The Przewalski’s horse (Equus ferus przewalskii) is the last remaining wild horse 
in existence today.  Once native to the Gobi Desert in Mongolia and China, the 
Przewalski’s horse is now considered critically endangered with 1,872 animals living in 
captivity and re-introduction sites in Mongolia, China and Kazakhstan (Lee and Boyd,
2008).  The current population is descended from only 14 founders captured from the 
wild over a period of time ranging from 1899 to 1947.  The species was declared extinct 
in the wild in 1970 by the International Union for Conservation of Nature (Lee and 
Boyd, 2008).  Recent conservation and re-introduction efforts have increased the 
number of individuals in the wild to 325 in Mongolia and 123 in China.  As a result, the 
status of this species has been upgraded to ‘Critically Endangered’ (Boyd et al., 2008).
Because there are no new founders available in the wild, the captive population 
serves as a genetic reservoir, or source population, for the re-introduced populations in 
Asia (Monfort et al., 2009).  The population in North America (123 individuals) is 
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managed by a Species Survival Plan (SSP; Monfort et al., 2009).  The Asian Wild Horse 
SSP uses mean kinship to prioritize breeding pairs that maximize gene diversity in the 
population (Monfort et al., 2009).  The pedigrees of all Przewalski’s horses in captivity 
are known, which facilitates genetic management; however, current gene diversity in the 
population is only 78.8%, which is significantly lower than the average for all mammal 
species managed by SSPs (93%; Monfort et al., 2009).  When gene diversity falls below 
90% of that in the founding population, it is expected that reproduction could be 
compromised due to neonatal mortality and decreased birth weights (Monfort et al., 
2009).
One challenge associated with the SSP-managed population is that some founders 
are overrepresented (Figure 2.1).  In this population, the average mean kinship is 0.2161, 
which indicates that each individual is related to 21.6% of the population (Monfort et 
al., 2009).  As a result, gene diversity is decreased.  This is further complicated by the 
small effective population size for this population (0.1867) (Monfort et al., 2009).  
Ideally, all animals in a population should be able to reproduce and produce offspring; 
however, the effective population size is the actual percentage of animals that are 
contributing genetics to a population (Wright, 1933).  This contributes to loss of genes 
and genetic drift, which can further impact reproductive fitness of the species.  To date, 
there has been no research on the effect of gene diversity on reproduction in the 
Przewalski’s horse.
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Figure 2.1:  Founder representation in the North American SSP population for the 
Przewalski’s horse.  Table lists population mean kinship and current gene diversity 
for the population (Monfort et al.., 2009).
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Because the current captive population in North America is skewed towards older 
animals, it is suspected that age-related fertility issues may be prevalent.  Currently, the 
average age of breeding mares in the North American population is 12.6 years (range, 2–
23 years) and 54% of breeding mares are over 10 years old.  According to data from the 
SSP on reproductive fecundity, a Przewalski’s mare aged 12 years would be expected to 
produce one foal every two years as compared to a 6-year old mare that produces one 
foal every year (Figure 2.2, Monfort et al., 2009).  During the past five years, an average 
of 8 live foals have been produced from 40 breeding pairs per year (20% foaling rate) –
a rate significantly lower than the live annual foaling rate of 50 - 60 % observed in the 
domestic horse (Ginther, 1992; Blanchard et al., 2004).
Assisted breeding, especially artificial insemination (AI) has been used as a tool to 
genetically manage ex situ populations of many wildlife species, such as the Giant Panda 
(Ailuropoda melanoleuca; Huang et al., 2002), African elephant (Loxodonta africanus; 
Hildebrandt, 2000), Asian elephant (Brown et al., 2004), Eld’s deer (Cervus eldii; 
Monfort et al., 1993) and scimitar horned oryx (Oryx dammah; Morrow et al., 2000), 
among others. However, success required preliminary efforts to establish baseline 
reproductive patterns in females such as seasonality, length of diestrus and estrus, and 
the timing of ovulation.  To date, four approaches have been used to study reproductive 
physiology of the Przewalski’s mare: 1) ultrasound evaluation of follicular structures 
(Durrant et al., 1986); 2) milk progesterone excretion (Zimmermann et al., 1985); 3) 
fecal progesterone metabolites (Schwarzenberger et al., 1992) and 4) urinary estrogen
metabolite excretion (Monfort et al., 1991).  Follicular growth patterns were assessed by 
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similar to what has been reported for the domestic horse (Durrant, et al., 1991). 
Figure 2.2:  Predicted number of offspring produced based on age (years).  For a 12-
year-old mare (indicated by arrow), only 1foal is produced every 2 years (Monfort et 
al., 2009).
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rectal ultrasonography in two mares that were each evaluated seven times over a three 
month period.  Based on their observations, follicular development and ovulation were 
However, because animals had to be anesthetized, animal numbers and the frequency of 
examinations were limited.  Additionally, no endocrine measures were available for 
correlating hormones with observed ovarian structures. 
Przewalski’s mares are still managed as wild animals, which makes it difficult to 
collect repeated blood samples for longitudinal endocrine assessments.  As a result, 
previous research has focused on the development and application of non-invasive 
techniques for analyzing steroid hormone and/or their metabolites in this species.  In one 
study, milk progesterone metabolites assessed in two lactating Przewalski’s mares 
revealed progesterone patterns that were similar to their domestic counterparts 
(Zimmermann et al., 1985).  After mating, the two mares exhibited a five to ten-fold 
increase in milk progesterone metabolites, which remained elevated until day 35 post-
ovulation.  After day 35, an additional two-fold increase in milk progesterone 
metabolites was observed, which was similar to the secondary rise in progesterone 
secretion in domestic mares (Ginther, 1992; Blanchard et al., 2004).  Although this 
study revealed important information about reproductive physiology in Przewalski’s 
mares, numbers of animals were limited (n = 2), in part, because sample collection was 
restricted to mares that would allow milk samples to be collected.  
A second study (Schwarzenberger et al., 1992) assessed fecal progesterone 
metabolites in non-pregnant Przewalski’s mares (n = 5).  Periodic increases in fecal 
progesterone metabolites during the breeding season were detected in four of five mares 
evaluated indicating the potential of fecal progestagen assessments for tracking ovarian 
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activity in this species, but data were insufficient for elucidating the endocrine features 
of the estrous cycle.  
The most extensive longitudinal assessment of reproductive endocrinology of 
Przewalski’s mares was accomplished by assessing urinary estrogen metabolites in 
eight Przewalski’s mares over a 19-month period (Monfort et al., 1991).  Estrogen 
excretion patterns confirmed reproductive seasonality for Przewalksi’s mares 
maintained in North America, and the onset of estrous cycles occurred coincident 
with increased day lengths.  Additionally, most copulations coincided with the peak 
of mid-cycle excreted estrogens across a 24-day ovarian cycle, and estrogen excretion 
was effective for diagnosing pregnancy.
Combining progesterone, estrogen, and follicular data would give the best 
estimation of ovulation timing, mainly because the horse has a longer period of estrus 
compared to other species (Koskinen et al., 1986).  Therefore, the objectives of this 
study are to: 1) characterize longitudinal profiles of urinary estrogen and progestagen 
metabolites; 2) describe follicular changes in relation to urinary hormone metabolites; 
and 3) assess changes in reproductive parameters based on age and mean kinship in 
Przewalski’s mares.  The hypotheses of this study were as follows:  1) differences exist 
in follicular changes and endocrine profiles between fertile and subfertile mares; and 2) 
mare age and genetic factors impact reproductive cycles.
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MATERIALS AND METHODS 
Animals:
Nineteen Przewalski’s mares (3-27 years of age) were included in the present 
study.  Fourteen mares were housed at the Smithsonian’s Conservation Biology Institute 
(SCBI) in Front Royal, Virginia (38.88° W, 78.17° N) and the remainder (n = 5) were 
kept at the Wilds in Cumberland, Ohio (38.82° W, 81.75° N).  All mares were kept in 
enclosures ranging in size from 0.5 to 50 acres. Table 2.1 shows ages, mean kinship, 
location and number of foals produced (up to 2007) for all mares used in this study.
Urine Collection:
Urine samples were collected three to seven days per week using the technique 
described by Monfort et al. (1991).  Briefly, freshly voided urine was aspirated with a 
clean syringe and kept cool until all samples were collected from all mares.  Samples 
were then placed in labeled glass tubes and centrifuged at 1,500 G for 15 minutes 
(centrifuge) to remove sediment and dirt.  Urine supernatant was then stored in plastic 
tubes at – 20  C until analysis was completed.  All samples (n = 7,517) were collected in 
the morning hours (7 AM to 12 PM).
Enzyme Immunoassay
Creatinine
Creatinine is secreted in urine and is an indication of glomerular filtration rate, 
therefore, to normalize all urinary samples based on dilution, all samples were indexed 
for creatinine (Cr) (Taussky, 1954).  For Cr determinations, raw urine was diluted to
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Table 2.1: Mares included in study. List shows age, mean kinship, number of live 
foals, location, and category of reproductive cycles based on endocrine or follicular 
data.
Mare





of Foals Location Category
4890 3 0.500 0 NZP Normal
4887 3 0.500 0 NZP Normal
2861 11 0.178 1 NZP Normal
3925 3 0.191 2 NZP Normal
2156 15 0.197 1 NZP Normal
2056 16 0.230 0 Wilds Normal
4350 4 0.181 1 NZP Normal
1363 21 0.183 1 Wilds Normal
4176 6 0.207 3 Wilds Normal
1866 17 0.227 2 Wilds Normal
1830 17 0.201 0 NZP Acyclic
1851 17 0.226 0 NZP Acyclic
2168 15 0.225 0 NZP Acyclic
3495 5 0.247 0 NZP Acyclic
1893 17 0.278 2 Wilds Acyclic
2050 16 0.200 0 NZP Abnormal
1035 24 0.221 1 NZP Abnormal
952 23 0.213 1 NZP Abnormal
3516 8 0.245 0 NZP Abnormal
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1:50 concentration in BSA – free phosphate buffer.  Diluted samples were added to 96-
well, flat bottom microtiter plates (Dynatech Laboratories, Inc., Chantilly, VA, USA), 
combined with 0.05 mL each of DH2O, 0.4 N picric acid, 0.75 N NaOH and incubated 
at room temperature (25°C) for 30 min.  Optical density (OD) was measured at 490 nm 
(reference 620 nm) using a microplate reader (Dynex MRX; Dynex Technologies, 
Chantilly, VA, USA).  Urine were run in duplicate and compared to reference Cr 
standards (0.00625 – 0.1 ng/mL, Sigma Aldrich, St. Louis, MO, USA).  Samples that 
had concentrations < 0.1 ng Cr/mL were considered too dilute and were run at a higher 
concentration (1:10 or 1:25). Samples that were < 0.1ng/mL Cr at a 1:10 dilution were 
discarded (2% of samples).  Hormone mass in a urine sample was divided by Cr 
concentration and expressed as mass of hormone/mg Cr (ng/mg Cr).
Estrogen EIA:
Urine samples were diluted (1:5 – 1:2000) in phosphate buffered solution and 
assayed in duplicate using the protocol outlined by Munro et al. (1991).  The antiserum 
(R522, Coralie Munro, University of California, Davis, CA, USA) cross-reacts with 
estrone-3-glucoronide (100%), estradiol-3-sulfate (66.6%), estrone (238%), estradiol-
17! (7.8%), estradiol-3-glucoronide (3.8%) and estradiol-3-sulfate (3.3%).  Sensitivity 
of the assay at maximum binding is 0.78 pg/well.  The inter assay coefficient of 
variation (CV) for the two internal controls was 11.49% (mean binding, 30.33%) and 
7.14% (mean binding, 65.59%) and intra-assy CV was < 10%.  Serially diluted urine 
samples demonstrated displacement curves parallel to those of standard hormone 
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preparations.  Recovery of added standard to urine (y = 0.82x + 1.07, r = 0.99) 
demonstrated significant recovery (P < 0.05).
Progestagen EIA:
Urine samples were diluted (1:10 – 1:400) in phosphate buffered solution and 
analyzed in duplicate using progestagen protocol described by Graham et al. (2001).  
The antiserum (CL425, Coralie Munro, University of California, Davis, CA, USA) 
cross-reacts with 4-pregnen-3,20-dione (100%), 4-pregnen-3"-ol-20-one (188%), 4-
pregnen-3!-ol-20-one (172%), 4-pregnen-11"-ol-3,20dione (147%), 5"-pregnan-3!-ol-
20-one (94%), 5"-pregnan-3!,20-dione (64%), 5"-pregnan-3,20-dione (55%), 5!-
pregnan-3!-ol-20-one (12.5%), 5-pregnan-3,20-dione (8%), 4-pregnen-11!-ol-3,20-
dione (2.7%), and 5!-pregnan-3"-ol-20-one (2.5%; Graham et al., 2001).  Sensitivity of 
the assay at maximum binding is 0.78 pg/well. The inter-assay CV for two internal 
controls was 12.99% (mean binding, 30.32%) and 6.95% (mean binding, 72.59%) and 
intra-assay CV was < 10%.  Serially diluted urine samples demonstrated displacement 
curves parallel to those of standard hormone preparations.  Recovery of added standard 
to urine (y = 0.99x – 0.48, r = 0.99) demonstrated significant recovery (P < 0.05).
Training for Ultrasound Examinations:
At SCBI, all females were subjected to an initial three-month training period to 
adapt to the chute and hydraulic tamer system that was designed to allow handling of 
large hoofstock species without the use of immobilizing drugs. Briefly, all mares were 
run through a custom-built chute system with an incorporated hydraulic tamer system 
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(Fauna Researh, Inc, Red Hook, NY, USA) that was positioned within the interior of the 
horse barn.  For a one-month period mares were worked through the chute system three 
days per week without being restrained.  During the second month, mares moved
through the chute system three days per week, were briefly restrained between the 
padded squeeze walls, and then released.  In the third month, mares were restrained and 
lifted in the hydraulic tamer once per week, but allowed to pass through the tamer 
without restraint on the other two days.  To lift the mares, the padded walls of the tamer 
were closed to secure the animals sufficiently to permit them to be raised off the ground 
(~ one foot) using the hydraulic lift.  This procedure provided sufficient immobilization 
to permit rectal examination.  Only personnel specifically trained in operating the tamer 
were allowed to restrain/lift mares for this project. During the study period (four – six
weeks), mares were restrained three days per week.  Mares that were not successfully 
restrained after three attempts, or mares that appeared too stressed, based on keeper and 
operator assessments, were released without examination.  On the off days (two days per 
week), mares went through the chute system as part of their morning routine before 
being let out to pasture.  On weekends, mares were not run through the system.  All 
mares received apple biscuits after leaving the tamer.  Mares were worked through the 
chute system at least one – two days per week as part of their daily routine throughout 
the entire period of reproductive studies (2006 – 2009).  
The hydraulic tamer and chute system at the Wilds is incorporated into their
veterinary facility.  Mares used for the study were moved from their pasture to the 
veterinary hospital 14 days before study onset.  Without preconditioning, these animals 
were moved through the chute system on days of ultrasound examinations (three days
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per week).  All mares received morning feed and alfalfa after the ultrasound procedure 
was performed.  Once the study was completed, all mares were returned to pasture with 
the rest of the herd.  To decrease stress, there were always three mares involved in the 
study so that no animals were by themselves at the veterinary facility.
Ultrasound Examination
This study was conducted in June to July 2006 (five weeks) and May to June 2008 
(five weeks).  Transrectal ultrasound exam was performed three days per week on 
Przewalski’s mares (SCBI: n = 7; Wilds: n = 3) using a portable B-mode ultrasound 
(SCBI: Sonovet 2000, Medison America, Inc, Cypress, CA, USA; Wilds: Aloka 500, 
Aloka America, Walingford, CT, USA) equipped with a linear transducer (4 to 7 MHz).  
Information on uterine edema, the presence or absence of endometrial fluid and ovarian 
structures (i.e., numbers of follicle, follicle size and the presence of corpus lutea [CL]) 
were recorded.  Other ovarian structures, such as ovulations and abnormal follicles were 
also noted.  To minimize stress, the total time during which each mare was in the tamer 
was held to less than five minutes.
Statistical Analysis
Endocrine studies
Yearly baseline concentrations of urinary estrogen conjugate and progestagen
metabolites for each female were determined using an iterative process (Brown, et al.,
1994). For urinary progestagen metabolites, values in excess of mean ± 2.0 standard 
deviations (SD) were removed. The average was then recalculated, and the
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elimination process repeated until no values exceeded the mean ± 2 SD remained.  
For urinary estrogen conjugate metabolites, values in excess of 2.5 SD of the mean 
baseline were removed until no values over 2.5 SD of the mean remained.  Urinary 
estrogen conjugate metabolite values were considered elevated if they remained 
elevated above baseline for three days and urinary progestagen metabolite values 
were considered elevated if they remained elevated above baseline for four days. 
To standardize profiles, steroid hormone metabolites were aligned to the day of 
peak urinary estrogen metabolites.  Data were analyzed -10 to +20 days from peak
urinary estrogens to assess an entire reproductive cycle based on previous study (24.1 
days; Monfort et al., 1991).  To avoid possible influence of the variable number of 
cycles per female, least square means were calculated for the population. Data were
presented as mean # SEM and graphed longitudinally using Delta Graph (Red Rock 
Software, Inc., Salt Lake City, Utah, USA).  Length of reproductive cycle was 
determined by calculating the interval between two urinary estrogen and progestagen 
peaks.  Days between urinary progestagen and estrogen peaks were then compared 
using a student’s t-test.  Mares were classified based on endocrine profiles as cyclic, 
abnormal and acyclic.  Mares were considered cyclic if they had an increase in 
urinary estrogens prior to increased urinary progestagens and discernible inter-estrus 
intervals. Abnormal mares exhibited cyclic patterns that were erratic with no regular 
inter-estrus pattern.  Acyclic mares had little to no urinary hormonal activity through 
the breeding season (March – August).  Data between groups of mares (mean urinary 
estrogens and progestagens) were then compared using Kruskal-Wallis one-way 
ANOVA and a multiple comparisons Dunn’s test.
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To determine whether independent factors influenced estrous cyclicity (as 
assessed using urinary estrogen and progestagen levels), linear regression was used to 
determine whether the independent variables age, mean kinship, or number of foals 
produced had an impact on levels of urinary estrogen or progestagen metabolites.  All 
analyses were conducted with SAS (version 9.2, Cary, NC, USA).
Follicular-Endocrine Comparison:
Endocrine data for intervals time-matched with ultrasound examinations were 
analyzed as described above with slight modification.  For cycling mares (n = 5), 
three-day rolling means were calculated for urinary estrogen and progestagen and 
these values were compared to corresponding observations of ovarian structures 
observed by ultrasound. Likewise, three-day rolling means of follicular size (mm) 
were calculated for ultrasound data.  Day 0 was defined as day of detected ovulation.  
Data were presented as mean # SEM and graphed longitudinally using Delta Graph 
(Red Rock Software, Inc., Salt Lake City, Utah, USA).  Because numbers of normal 




Baseline endocrine profiles for the Przewalski’s mares (number of mares = 14; 
n = 1,064 urine samples) were analyzed from March to September for one breeding 
season during which no rectal palpations were performed.  Based on these profiles, 
mares were grouped into three categories: cyclic (number of mares = 7; n = 518 
samples), abnormal (number of mares = 3; n = 228 samples) and acyclic (number of 
mares =4; n = 304 samples).  Cyclic mares exhibited an obvious estrogen peak 
preceding an increase in urinary progestagen (Figure 2.3), and exhibited regular 
intervals between the two steroid peaks (peak estrogen interval: 25.2 # 1.2 days; peak 
progestagen interval: 25.1 # 1.2 days). Hormone profiles for mares that exhibited 
abnormal estrous cycles are depicted in Figure 2.4. Two of the three mares (Fig. 2.4a,
b) showed no obvious rise in progestagen excretion after the estrogen peak. The peri-
ovulatory estrogen peak was absent in the third mare, although a brief increase in 
progestagen excretion was observed (Fig. 2.4c).  For the acyclic mares (n = 4, Fig.
2.5), there were no discernable trends in urinary hormone excretion, and steroid 
metabolite concentrations (both estrogens and progestagens) were baseline in 90% of 
the samples evaluated.
In mares with normal endocrine cycles, mean urinary progetagen metabolites
increased 7.1 # 0.7 days after the first detectable rise in mean urinary estrogen and 4.9
# 0.9 days after the mean estrogen peak. The interval during which urinary 
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Figure 2.3: Mean urinary hormone metabolites (estrogens and progestagens) from 
Przewalski’s mares (n = 7 mares; n = 518 urine samples).  Data are shown as mean #
SEM.  Data were aligned in relation to peak urinary estrogen (Day 0).
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Figure 2.4 a., b, and c:  Przewalski’s mares (n = 3 mares; n = 228 urine samples) 
showing mean longitudinal profiles for n = 3 cycles.  Error bars depict SEM.
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Figure 2.5: Representative longitudinal urinary hormone data for acyclic 
Przewalski’s mare (n = 1mare; n = 304 urine samples).
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progestagen was elevated was consistent among normal mares (range, 9.3 – 13.3
days), whereas there was considerable variation in duration of time that urinary 
estrogen remained elevated above baseline (range: 9 – 18 days).  It was also noted 
that urinary estrogen was increased in three mares (3/7, 42%) coincident with periods 
during which urinary progestagen was also elevated.
Mean urinary estrogen and progestagen concentrations (Fig. 2.6) among cyclic, 
abnormal and acyclic mares were different (P< 0.05).  Urinary estrogen and 
progestagen concentrations in cyclic mares were elevated (100.8 # 4.1 and 44.7 # 2.2
ng/mg Cr, respectively) compared to abnormal (77.7 # 3.0 and 41.9 # 3.3 ng/mg Cr,
respectively) and acyclic mares (14.4 # 1.2 and 11.7 # 0.5 ng/mg Cr, respectively).
Likewise, urinary estrogen and progestagen concentrations in abnormal mares 
exceeded (P< 0.05) those observed in acyclic females.
Based on linear regression analysis, mean kinship had a significant effect (r
2
=
0.476; P < 0.05) on mean levels of urinary estrogen metabolites in all mares analyzed 
(n = 13 mares). However, no other independent variables showed an effect on levels 
of either urinary estrogen or progestagen excretion. 
Ultrasound Data:
A total of 268 ultrasound examinations were performed on nine Przewalski’s 
mares in 2006 and 2008.  Based on ultrasound data, mares were also classified into 
three groups: Cyclic, Abnormal and Acyclic.  Cyclic mares had follicular 
development with regular patterns and depicted a normal ovulation.  Abnormal mares 
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Figure 2.6: Bar chart showing the mean # SEM of mares based or normal, abnormal, 
or acyclic endocrine profiles.  Letters significant difference between groups (P <
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would also show follicular development; however, these resulted in the development 
of hemorrhagic follicles.  Acyclic females showed no follicular development (4/9, 
44.4%; n = 120 palpations) or ovulations.  Regular ovarian cycle patterns were 
detected in four mares with normal follicular development; one had cyclic patterns 
with abnormal structures (1/9, 11.1%), one exhibited a normal cycle in one study 
period and was abnormal in the other period (1/9, 11.1%), and three mares (3/9, 33%,
n = 12 palpations) experienced no follicular activity throughout the study period. 
Ovaries were noticeably smaller in acyclic mares (20 x 10 mm) with no detectable 
follicular structures and small flaccid uteri (tone 0/3).  Normal mare ovaries varied in 
size, depending on follicular activity but ranged in from 50 - 60 mm x 25 - 40 mm.  
Ovaries in abnormal mares were comparable in size to normal mares.
Urinary estrogen concentrations increased with increased follicular diameter 
(Figure 2.7). In the nine cycles analyzed, 2 (2/9, 22%) of the mares had double 
ovulations: one synchronous and another asynchronous.  Among all mares, a urinary 
estrogen peak was detected during the interval extending from two days before to
four days after ovulation (mean, -0.4 # 0.6 days), and urinary progestagen peaked 
from zero to six days after detected ovulation (mean, 1.9 # 0.8 days). Inter-ovulatory 
cycles were detected in three instances whereby mares exhibited two separate 
ovulations across a five week interval.  In these instances the ovulation-to-ovulation 
interval was 22.2 # 0.9 days (range, 21 – 24 days).  Average follicle size at ovulation 
amongst all mares was 40.4 # 89.4 mm (range: 31 - 48 mm; n = 14 observations).
Dominant follicles, defined as a follicle > 30 mm diameter in the absence of a CL, 
grew at a rate of 1.2 # 0.6 mm/day (range: 0.5 to 2.7 mm) over a period of 9.2 # 0.4
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Figure 2.7:  Changes in urinary estrogen metabolites in relation to follicular size in 
Przewalski’s mares (n = 4 mares).   Upper figure shows urinary estrogen metabolites 
(Mean # SEM) in relation to ovulation day (Day 0).  Lower figure shows follicular 
size (Mean # SEM) in relation to ovulation.
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days (range: 8 to 11 days) before reaching ovulation.  The duration of a detectable CL 
on the ovary by rectal ultrasound was 12.2 # 0.87 days.
There was no difference (P > 0.05) between the number of days a CL was 
detected by ultrasound and the number of days during which urinary progestagen was 
increased.  There also was no significant difference (P > 0.05) between inter - estrous
interval estimates using either hormones (i.e., urinary estrogen or progestagen peaks) 
or ovulation detection by ultrasonography.
DISCUSSION
This was the first study to combine assessments of reproductive steroids with 
direct observations of follicular dynamics to classify ovarian cycles in the 
Przewalski’s horse.  Results indicated that 50% of mares either exhibited abnormal 
estrous cycles or were acyclic.  Of major signficance, we determined that abnormal 
cycles and acyclicity appear to be linked to loss of genetic diversity in this species.  
Longitudinal patterns of urinary estrogen excretion were previously assessed to 
establish that the Przewalski’s mare is a seasonally polyestrous breeder (Monfort, et 
al., 1991, Zimmermann et al., 1985). Our additional longitudinal assessments of 
urinary progesterone excretion and serial ultrasonography revealed new insights into 
the estrous cycle of the Przewalski’s mare.  In particular, behavioral pre-conditioning 
for manual restraint permitted serial ultrasonography in unsedated mares, which 
provide a more comprehensive assessment of the ovarian cycle.  
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The inter-estrous interval estimates derived from this study using all three 
parameters (i.e., urinary estrogens, progestagens and rectal ultrasound) was similar to 
what has been previously reported (Monfort et al., 1991). Likewise, the estrous cycle 
length averaged 25.2, 25.1 and 22.2 days based on urinary estrogens, progestagens 
and ovulation detection, resepectively, which was similar to the 24.1-day cycle length 
reported previously (Monfort et al. 1991).  These estimates slightly exceed those 
reported for the domestic mare, which typically lasts 21 - 22 days (range: 18 – 24
days) (Blanchard et al., 2003), although many pony breeds exhibit estrous cycles in 
the range of 24 – 26 days (Ginther, 1992).  The variable range in domestic mares is 
often attributed to the length in estrus, whereas diestrus appears to remain relatively 
constant at approximately 14 days (Ginther, 1992).  Similar to the domestic horse, the 
period of increased urinary progestagen metabolites was fairly constant in 
Przewalski’s mares (9 – 13 days), whereas the period of increased urinary estrogen 
metabolites was quite variable (9 – 18 days).  
In normal cycling mares, urinary progestagens increased 7.1 # 0.7 days after an 
increase in urinary estrogens.  Despite the limited numbers of mares assessed, there 
was little variation among individuals (range, 6.8 – 8.8 days).  Ultrasound data were 
consistent with the estimates derived from endocrine assessments and the interval
from the first significant increase in estrogen to ovulation was 6.4 # 1.3 days.  These 
data are especially important because they validate the use of urinary estrogen 
monitoring as a tool for pinpointing the most appropriate time for performing 
artificial insemination, a process that has been used successfully in other wildlife 
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species such as the Giant Panda (Aiuropoda melanoleuca; Huang et al., 2002) and the 
bottle nose dolphin (Lagenorhynchus obliquidens; Roebeck et al., 2005).
In a substantial number of mares (2/7, 28.6% with hormone monitoring only; 
4/5, 80% with hormone monitoring plus ultrasound), urinary estrogen metabolites
were increased coincident with periods of elevated progestagen excretion.  For the 
subset subjected to ultrasound examination, a secondary wave of follicular growth 
was confirmed in the presence of a CL.  These findings are similar to those previously 
found by Monfort et al., (1991) where a secondary rise in urinary estrogens occurred 
four to eight days post peak in urinary estrogens.  In the domestic mare, urinary 
estrogens also increase four to seven days post-ovulation (Ginther, 1992).  It is 
believed that the secondary increase in estrogens observed in the domestic horse may 
reflect estrogen produced by a secondary follicular wave during the post-ovulatory 
interval.
Based on rectal ultrasound, the growth rate of follicles was less than that 
previously observed for this species (three to five mm/day; Durrant et al., 1986) and 
also less than the domestic horse, in which follicles increase three mm per day from 
day -5 to day -2 and remain static until 12 hours pre-ovulation (Ginther et al., 2004).
In the present study, we found that follicles increased 1.2 # 0.2 mm/day (range, 0.66 –
2.67 mm per day).  For the final two to four days before ovulation, follicle size 
actually decreased in 33% (3/9) of mares, whereas size increased in 55% (5/9) of the 
cases.  We speculate that the differences observed here relative to previous results 
(Durrant et al., 1986) may relate to the number of mares studies (five vs. two mares) 
and the fact that the current study included more frequent examinations (19 – 29
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examinations for each mare in a five week period vs. seven examinations for each 
mare in a three month period). Nevertheless, the overall sample size for both studies 
is small, and additional study is needed to clarify the time course and dynamics of 
follicular growth in this endangered species.
In most species, a dominant follicle produces estrogen under stimulation of 
follicle stimulating hormone (FSH) and LH (Senger, 2003). In many ungulate 
species, such as the cow, ewe and sow, the period of estrus is short (15, 30, and 50 
hours; Senger, 2003).  However, in the domestic horse, estrogens increase over a 
period of at least five days coincident with follicular growth (Ginther, 1993; Ginther
et al., 2003). In the present study, urinary estrogens were elevated (7.8 ± 0.6 days 
prior to ovulation) in parallel with follicular diameter, which suggests that the 
follicular-endocrine dynamics in the Przewalski’s mare are similar to the domestic 
horse.
Like the domestic horse (Ginther, 1986), ultrasound examinations indicated that 
ovulations in the Przewalski’s mare were mono-ovulatory (7/9, 77.8%), whereas a 
minority of mares (2/9, 22.2%) exhibited double ovulations.  While the sample size is 
small, 22.2% double ovulations would be considered high in the domestic horse, and 
is similar to the percentage observed in Thoroughbred mares (15 – 25%; Blanchard et 
al., 2004).  In this study, a synchronous double ovulation was observed in a single 
mare, with ovulation synchrony of < 1 day.  Another mare exhibited an asynchronous 
double ovulation, with the second ovulation occurring 2 days after the first.  
Interestingly, elevated urinary estrogens excretion persisted until after the second 
ovulation.  There are many factors that could be responsible for double ovulations in 
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mares, including increased sensitivity to gonadotrophins, genetics, age and season 
(Ginther, 1992).  In the present study, both mares were over the age of 15 years, and 
this finding provides incentive for further exploring the relationship between age and 
ovarian function.
Our analyses revealed that urinary estrogen excretion peaked -0.37 # 0.59 days 
from ovulation, although there was substantial among-mare variation (-3 - +4 days).  
By comparison, serum estrogen in the domestic mare peaked two days before
ovulation, but among-animal variation was also reported to be high (Koskinen et al., 
1989).  Species differences in timing of the pre-ovulatory estrogen peak may be an 
artifact of the time-lag (>24 hours in the horse) between the secretion of estrogen in 
blood circulation and the excretion of its metabolites in voided urine (Lasley and 
Kirkpatrick, 1991). Urinary progestagens increased 2.2 # 1.9 days post urinary 
estrogen peak, but among-animal variation was substantial (range, zero to six days 
post-ovulation). Understanding timing of ovulation in relation to urinary estrogen 
peak could provide important information for attempting breeding by AI, especially 
in institutions that do not have handling facilities for large ungulates.  Further studies 
need to be conducted on normal cycling mares to further confirm timing between 
urinary estrogen peak and ovulation in order to determine whether timed AI in 
relation to peak urinary estrogens is feasible. 
This is the first study to demonstrate that an increase in mean kinship influences 
cyclicity in Przewalski’s mares.  Estrogen production was directly influenced by 
mean kinship of Przewalski’s mares.  Since estrogen is an indication of follicular 
development, this is an indication that inbreeding has an impact on reproduction in 
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this species.  While the SSP recommends breeding based on mean kinship, these 
results indicate that continued genetic management is important in this population.  
While we were unable to look at founder effects on reproduction due to limited 
numbers, it would be important to see if particular founders have an impact on 
fertility.  This is important because the SSP determines breeding pairs based on mean 
kinship, which only reflects heterozygosity, not possible deleterious genes from a 
founder line that may be impacting fertility.  Future studies should assess whether 
females that are acyclic may have common founders to determine whether these 
animals should be represented less in the population.
Detailed descriptions of follicular and endocrine traits in Przewalski’s mares 
studied across two locations revealed that a high proportion of mares exhibited 
abnormal ovarian cycles.  Strikingly, mean kinship appeared to have a significant 
negative effect on ovarian function (i.e., hormone and ovarian morphology).  These 
results should be a “wake up” call for the zoological community, which has only 
recently begun to come to grips with the fact that many of their managed breeding 
programs are unsustainable with current management and breeding strategies (Lees 
and Wickens, 2009).  While Przewalski’s horse reintroductions to-date have been 
successful, recent die-offs in the Gobi B Takhi Project in Mongolia reinforce the 
continued importance of captive horse populations as vital insurance against 
unanticipated catastrophes, and as a continuing source of animals for future 
reintroduction.  However, zoo-based managed breeding programs are at risk, in part, 
because of failure to achieve their management goals.  In a recent analysis of 87 
managed populations, only 48% were capable of sustaining current population 
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numbers and only 55% were retaining gene diversity at or above 90% of founder 
stock (Lees and Wickens, 2009).  The Przewalski’s horse SSP is already depleted 
(i.e., 78% gene diversity), and concerted efforts are necessary to prevent further 
losses of gene diversity.  We contend that there is a need for much more basic science 
to understand the relationships between gene diversity, age and fecundity in small 
populations.  Our results clearly demonstrate it is possible to gain an improved 
understanding of reproductive mechanisms using existing, well-estabished tools such 
as noninvasive endocrine monitoring and ultrasonography.  Equally important, 
however, is the need for specialized facilities and expertise in animal husbandry, 
management and behavioral conditioning that are dedicated to conducting science on 
some of the most under-studied, and endangered animals on the planet.
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CHAPTER THREE
Manipulation of the Estrous Cycle in Przewalski’s Mares
INTRODUCTION
The Przewalski’s horse (Equus ferus przewalski) is a wild horse that is native to 
Central Asia, which is now considered critically endangered (Boyd et al., 2008).  Because no 
new wild founders exist, genetic management of the ex situ population is critical for long-
term survival of the species. Przewalski’s horses are large mammals and many zoological 
parks lack sufficient space for appropriate breeding and genetic management, especially 
management of bachelor bands.  As a result, these equids exist in small fragmented 
populations that are vulnerable to losses of genetic diversity, especially since it has been 
shown that Species Survival Plans (SSPs) do not always effectively manage captive 
populations due to failure of institutions to follow through with breeding recommendations 
(Lees and Wicken, 2009). Successful application of assisted reproductive technologies, 
especially artificial insemination (AI), has been shown to enhance breeding management of 
ex situ wildlife populations (Holt et al., 1998; Wildt et al., 1992; Pukazhenthi and Wildt, 
2004).  However, early studies in ungulates and great cats have shown that AI technology 
developed for domestic species is of little value for many wildlife species (Pukazhenthi and 
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Wildt, 2004).  Developing AI as a routine tool for managing genetic diversity of ex situ 
Przewalski’s horse populations requires pre-emptive research designed to understand the 
reproductive physiology of this species, including how to regulate ovarian activity.  
In species such as the Przewalski’s horse, AI requires anesthesia of stallions to collect 
semen, which carries risks for the animal as well as the personnel conducting the procedure.  
Additionally, the success of estrous synchronization and timed AI is enhanced when multiple 
mares can be managed in small enclosures connected to facilities that permit animals to be 
readily shifted and safely restrained for insemination.  Timed AI has been developed in many 
ungulate species, such as the scimitar horned oryx (Morrow et al., 2000), yaks (Zi et al., 
2006), dolphin (Robeck et al., 2009) and the Indian blackbuck (Sontakke et al., 2009).  For 
many of these species, manipulation of the estrous cycle has been adapted from exogenous 
hormone treatments that were first applied to domestic species such as the cow, sow and 
mare.  In the domestic mare, reproductive cycle management has been challenging, largely 
due to the long and variable follicular phase (2-18 days), which is also modulated by seasonal 
effects (Bergfelt, 2000; Ginther, 1993).  In normally cycling mares, timing of estrus can be 
manipulated by shortening or lengthening the luteal phase of the cycle using several 
exogenous hormone treatments, including prostaglandins (PGF2 ), progesterone (synthetic 
and natural forms) and estrogen, either alone or in various combinations (Bristol, 1993; 
Bergfelt, 2000).  PGF2 is very effective at shortening the luteal phase of the estrous cycle; 
however, it has very limited efficacy when used alone, particularly early (zero to five days 
post-ovulation) in the lifespan of the corpus luteum (CL, Bergfelt, 2000; Bristol; 1993).  
Single injections yield wide variation in the number of days from hormone administration to 
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detected estrus (5.1 ± 0.3 to 9.0 ± 0.7 days) depending on the size of follicle at time of 
injection (Loy et al., 1979; Hughes and Loy, 1978).  
Exogenous progesterone therapy has been used to manipulate timing of estrus in the 
mare (Bergfelt, 2000; Senger, 2003).  Progesterone suppresses luteinizing hormone (LH) 
secretion from the pituitary gland, which in turn prevents final maturation and ovulation of 
dominant follicles (Bergfelt, 2000; Senger, 2003).  Because of this mechanism, the response 
of mares to progestagens, in theory, is not affected by stage of the estrous cycle (Bristol, 
1993).  Progesterone is usually administered for 15 – 18 days, which artificially prolongs the 
luteal phase, thereby permitting additional time for the natural regression of any existing CLs 
while preventing subsequent ovulations (Bristol, 1993; Senger, 2003).  The disadvantage of 
native progesterone is that it must be administered via daily intramuscular injections, and its 
use does not result in adequate synchronization of estrus (Holtan et al., 1977).  For example, 
the treatment of 21 pony mares with progesterone (18 consecutive daily injections) and 
human chorionic gonadotropin (hCG, administered 6 days after the final progesterone 
injection) resulted in a 52.4% response rate.
Because the use of injectable progesterone is labor intensive and resulted in poor 
estrous response, synthetic progestagens, including altrenogest and melegesterol acetate 
(MGA) have been developed and utilized with more promising results (Bristol, 1993; 
Bergfelt, 2000).  Estrous synchronization can be achieved through the oral administration of 
these progestagens for as few as 14 days in the domestic mare.  Estrus and ovulation in nine 
mares subjected to a 15-day oral altrenogest treatment regimen occurred three to six days and 
eight to fifteen days after treatment onset, respectively (Squires et al., 1979; 1983).  In the 
domestic mare, exogenous progestagens have little effect on follicle stimulating hormone 
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(FSH) secretion and the growth of follicles that exist before hormone treatment onset 
(Squires et al., 1983).  Therefore, among-mare differences in follicle size at the time of 
progestagen-treatment cessation are substantial, which results in wide variation in the interval 
of time from progestagen withdrawal to ovulation.  Initial studies highlighted the positive 
benefits of altrenogest (Squires et al., 1979; 1983; Turner et al., 1981), but subsequent 
research demonstrated that altrenogest used alone did not consistently prevent ovulation (and 
CL formation) during the treatment period, which resulted in unacceptable variability in the 
interval from treatment cessation to ovulation (Lofstedt and Patel, 1989).  As a result, PGF2
In the domestic mare, LH increases over three to five days during the peri-estrus 
interval, and typically peaks one to two days post-ovulation.  Thus, estrus is prolonged in the 
mare relative to other species, which complicates efforts to pinpoint ovulation (Palmer, 1978; 
Senger, 2003; Gastal et al., 2000; Ginther, 1992).  Ovulatory agents are used in mares to 
enhance the predictability of ovulation timing, especially when AI is used.  Currently, there 
are three commercially available ovulatory agents: hCG, Deslorelin (GnRH analogue), and 
recombinant equine LH (Samper, 2008).  Ovulation occurs in mares 24 – 48 hours post-hCG, 
which is a protein that exhibits LH activity (Blanchard et al., 2004; Samper, 2000).  Because 
mares can develop antibodies to hCG, it is undesirable for repeated use in the same mare 
(Barbacinni et al., 2000).  Deslorelin is available in two forms: a biodegradable implant and a 
compounded liquid form (Samper, 2008).  The implant form is very effective for inducing 
ovulation within 38 – 42 hours of administration.  However, unless implants are removed, 
some mares experience delayed return to estrus due to the continued release of GnRH, which 
 
administered at the end of the progestagen treatment interval, is now routinely used to regress 
any CL that may have developed during alternogest treatment (Bergfelt, 2000).
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results in negative feedback on the anterior pituitary (McCue et al., 2002).  The compounded 
biorelease form of deslorelin (Betpharm, Inc., Lexington, KY, USA) reliably induces 
ovulation within 40 – 60 hours of treatment without any evidence of delayed return to estrus 
(Samper, 2008, Burns et al., 2006).  Recombinant eLH is a single chain gonadotrophin that is 
a smaller protein than hCG.  While eLH has only recently been available for ovulation 
induction in the mare, its efficacy has been comparable to hCG (Yoom et al., 2007).  In 
Przewalski’s mares, it has been shown that hCG was not effective for inducing ovulation 
within 24 hours of injection (Durrant et al., 1986).  However, because there were limited 
ultrasound examinations, ovulation may have been missed or hCG may have been given at a 
suboptimal time in the estrous cycle.
To date, manipulation of the estrous cycle with hormone therapy has not been 
attempted in the Przewalski’s horse. Similar to the domestic mare, the Przewalski’s horse
exhibits similar reproductive-endocrine patterns, including seasonally polyestrous cycles that 
last 24 – 25 days (Monfort et al., 1991). The objectives of this study are to assess the 
efficacy of estrus induction using: a) the combination of oral alternogest and PGF2 ; b) 
injectable altrenogest; and c) to determine whether ovulatory agents, deslorelin and eLH 
reliably induce ovulation in Przewalski’s mares.
MATERIALS AND METHODS
Animals
Eleven Przewalski’s mares from two institutions were used in this study.  Three 
females (7 – 20 years of age) were housed at the Wilds near Cumberland, Ohio (39.82° N, 
81.75° W).  Eight mares (2 – 25 years of age) were housed at Smithsonian Conservation 
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Biology Institute (SCBI; 38.88° N, 78.17° W) near Front Royal, Virginia.  All animals were 
housed in small groups (two to six animals per group) on dirt lots with access to barns or 
shelter.  Animals had access to fresh water, good quality hay, and mineral blocks throughout 
the study period.  
Urine Collection:
Urine samples were collected three to seven days per week using the technique described by 
Monfort, et al. (1991).  Briefly, freshly voided urine was aspirated with a clean syringe and kept 
cool (4 to 6°C) until all samples were collected from all mares.  Samples were then placed in 
labeled glass tubes and centrifuged at 1500 G for 15 minutes to remove sediment and dirt.  
Urine supernatant was then stored in plastic tubes at – 20 !C until analysis was completed.  All 
samples (n = 965) were collected in the morning (0700 – 1100 h).
Enzyme Immunoassay
Creatinine
Creatinine is secreted in urine and is an indication of glomerular filtration rate, therefore, to
normalize all urinary samples based on dilution, all samples were indexed for creatinine (Cr) 
(Taussky, 1954).  For Cr determinations, raw urine was diluted to a 1:50 concentration in BSA 
– free phosphate buffer.  Diluted samples were added to 96-well, flat bottom microtiter plates 
(Dynatech Laboratories, Inc., Chantilly, VA, USA), combined with 0.05 mL each of DH2O, 0.4 
N picric acid, 0.75 N NaOH and incubated at room temperature (25°C) for 30 min.  Optical 
density (OD) was measured at 490 nm (reference 620 nm) using a microplate reader (Dynex 
MRX; Dynex Technologies, Chantilly, VA, USA).  Urine were run in duplicate and compared 
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to reference Cr standards (0.00625 – 0.1 ng/mL, Sigma Aldrich, St. Louis, MO, USA). Samples 
that had concentrations < 0.1 ng Cr/mL were considered too dilute and were run at a higher 
concentration (1:10 or 1:25). Samples that were < 0.1ng/mL Cr at a 1:10 dilution were 
discarded (2% of samples).  Hormone mass in a urine sample was divided by Cr concentration 
and expressed as mass of hormone/mg Cr (ng/mg Cr).
Estrogen Conjugate EIA:
Urine samples diluted (1:5 – 1:2000) in phosphate buffer were assayed in duplicate using 
the protocol outlined by Munro et al. (1991).  The antiserum (R522, Coralie Munro, University 
of California, Davis, CA, USA) cross-reacts with estrone-3-glucoronide (100%), estradiol-3-
sulfate (66.6%), estrone (238%), estradiol-17" (7.8%), estradiol-3-glucoronide (3.8%) and 
estradiol-3-sulfate (3.3%).  The inter assay coefficient of variation (CV) for the two internal 
controls was 11.49% (mean binding, 30.33%) and 7.14% (mean binding, 65.59%) and intra-
assy CV was < 10%.  Serially diluted urine samples demonstrated displacement curves parallel
to those of standard hormone preparations.  Recovery of added standard to urine (y = 0.82x + 
1.07, r = 0.99) demonstrated significant recovery (P < 0.05).
Progestagen EIA:
Urine samples diluted (1:10 – 1:400) in phosphate buffer were analyzed in duplicate using 
the protocol described by Graham et al. (2001).  The antiserum (CL425, Coralie Munro, 
University of California, Davis, CA, USA) cross-reacts with 4-pregnen-3,20-dione (100%), 4-
pregnen-3 -ol-20-one (188%), 4-pregnen-3"-ol-20-one (172%), 4-pregnen-11 -ol-3,20dione 
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(147%), 5 -pregnan-3"-ol-20-one (94%), 5 -pregnan-3",20-dione (64%), 5 -pregnan-3,20-
dione (55%), 5"-pregnan-3"-ol-20-one (12.5%), 5-pregnan-3,20-dione (8%), 4-pregnen-11"-ol-
3,20-dione (2.7%), and 5"-pregnan-3 -ol-20-one (2.5%) (Graham et al., 2001).  Sensitivity of 
the assay at maximum binding is 0.78 pg per well. Sensitivity of the assay at maximum 
binding is 0.78 pg per well. The inter-assay CV for two internal controls was 12.99% (mean 
binding, 30.32%) and 6.95% (mean binding, 72.59%) and intra-assay CV was < 10%.  Serially 
diluted urine samples demonstrated displacement curves parallel to those of standard hormone 
preparations.  Recovery of added standard to urine (y = 0.99x – 0.48, r = 0.99) demonstrated 
significant recovery (P < 0.05).
Ultrasound Examination
Transrectal ultrasound was performed three days per week (SCBI: n = 8 mares; the Wilds: n 
= 3 mares) using a portable B-mode ultrasound (SCBI: Sonovet 2000, Medison America, Inc, 
Cypress, CA, USA; Wilds: Aloka 500, Aloka America, Walingford, CT, USA) equipped with a 
linear transducer (4 - 7 MHz).  To decrease variability associated with time of year, mares held 
at SCBI and the Wilds were subjected to rectal ultrasound examinations during the same period 
by two researchers that each have a minimum of two years of experience performing rectal 
ultrasound on domestic horses.  The studies were conducted during five week intervals from 
May to August 2007, May to July 2008 and May to June 2009.  Briefly, mares were 
manipulated through a chute system and briefly restrained within a padded hydraulic squeeze 
apparatus (Fauna Research, Inc, Red Hook, NY, USA).  Researchers evacuated feces from the 
mare’s rectum and quickly palpated the reproductive tract to gauge ovarian structures, uterine 
and cervical tone.  The ultrasound examination was then performed by introducing a linear 
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transducer into the rectum, which permitted visualizing uterine edema, presence or absence of 
endometrial fluid and ovarian structures.  Follicles were assessed and measured electronically.
Other ovarian structures, such as ovulations, anovulatory follicles or CLs were also noted.  To
minimize stress, the total time during which the mare remained in the tamer was kept below five 
minutes.
Study 1:
Rectal ultrasound was used to assess follicular structures in cycling females (SCBI, n = 3 
mares; the Wilds, n = 2 mares) three time per week during a three-week pre-treatment 
interval.  Altrenogest (Regumate®:  DPT Laboratories, San Antonio, TZ, USA; Dose: 0.044 
mg/kg per os) mixed in sweet feed was then administered to all mares for a period of 14 days
(O14; Figure 3.1). On day 12, all mares received i.m. injections of PGF2 (12.5 !g
cloprostenol, Betpharm, Inc, Lexington, KY, USA) to lyse any remaining luteal structures on 
the ovaries.  On days 15 – 20, mares were examined daily by rectal ultrasonography.
Follicular structures were measured and any ovulations were noted.  Once a follicle > 35mm
was observed, one of three treatments was administered by intramuscular injection:
Treatment 1, saline (1 ml); Treatment 2, recombinant eLH (0.75 mg reLH, Dr Jan Roser, 
University of California, Davis, CA, USA); and Treatment 3, GnRH analog (1.5 mg 
Biorelease deslorelin, BETPharm, Lexington, KY, USA). The number of days from 
treatment administration to ovulation was recorded. Mares were then given a two-week 
period of rest before the study was repeated.  All mares were rotated through treatment 
regimens one to three times (SCBI: three treatment cycles; the Wilds:  one treatment cycle),
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Oral Altrenogest Ovulation Induction
Figure 3.1: Schematic of hormone therapy in study 1.  Altrenogest therapy was given for 
fourteen days.  On day 12, PGF2 was injected.  Mares were then checked for estrous 
follicle from days 15 – 21 and given an ovulatory agent (GnRH, reLH, saline).
totaling 11 treated cycles within the study period.  Mares at SCBI received all treatments and, 
therefore served as their own controls.  Urine samples were collected from all mares 
throughout the entire period (May – September 2007) and stored at -20 C until analyzed by 
EIA, as previously described.
Study 2:
Cycling females (n = 10) at two institutions (SCBI, n = 8; the Wilds, n = 2) were used in 
this study.    In 2008, all mares were examined three days per week by rectal ultrasound for 
follicular structures starting three weeks before treatment onset.  In this study, two treatments 
were used on two groups of mares.  Treatment 1 [O12 Treatment] consisted of oral Regumate 
(0.044 mg/Kg/day, DPT Laboratories, San Antonio, TX, USA) administered to five mares 




intramuscular injection of long-acting biorelease altrenogest (150 mg, Betpharm, Inc.) 
administered to five SCBI mares (Figure 3.2).  On day 10 of treatment, all mares were 
injected with PGF2 (12.5 !g cloprostenol, Betpharm, Inc). Mares were then examined 
daily by rectal ultrasound for follicular development or ovulation.  When a follicle > 35mm 
was detected, a GnRH agonist (1.5 mg Biorelease deslorelin, BetPharm, Inc.) was given to 
induce ovulation.  In 2009, mares were only examined by rectal ultrasound on days 13 – 20
after treatment by injectable altrenogest to minimize stress associated with handling.  Once a 
35 mm follicle was detected, GnRH was injected to induce ovulation. To compare the 
response to GnRH, data from mares treated with GnRH were compared to natural cycles 
from previous year where no treatment was given (n = 10 mares).  Urine samples were 
collected throughout the study period (May to July 2008, 2009), which included a four-week 
pre-treatment interval.  Samples were frozen and stored at -20 C until analyzed by EIA for 
urinary estrogen and progestagen metabolites, as described previously.
Statistical Analysis:
Baseline hormone values were determined using an iterative process (Moreira et al.,
2001). For urinary progestagen metabolites, values in excess of the mean ± 2.0 standard 
deviations (SD) were removed.  The average was then recalculated, and the elimination
process repeated until no values that exceeded the mean ± 2 SD remained. For urinary 
estrogen conjugate metabolites, values in excess of 2.5 SD of the mean baseline were 
removed until no values that exceeded 2.5 SD of the mean remained.  Urinary estrogen
conjugate metabolite values were considered elevated if concentrations were elevated above
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Oral Group (n = 5)
Day
Injectable Group (n = 5) Year 1 Year 2 (n = 5)
Figure 3.2: Schematic of hormone therapy for study 2.  Przewalski’s mares received 
either oral altrenogest daily or one injection of biorelease altrenogest.  Ovulation was induced 
by GnRH agonist, Deslorelin.
baseline for three days, whereas urinary progestagen metabolite values were considered 
elevated if they concentrations were elevated above baseline for four days.
Standard descriptive statistics including mean and standard error of mean (SEM) were 
used to summarize data.  For comparative purposes, each study period was divided into three 
periods: pre-, peri-, and post-treatment.  Pre- treatment was ten days before treatment onset;
peri – treatment was the actual treatment period (12 to 14 days); and post – treatment was the 
ten day period after treatment cessation.  Hormonal data among periods and treatments were 
analyzed using one-way analysis of variance (ANOVA) (GraphPad Prism, Version 5.03, La 
Jolla, CA, USA).  Non-normally distributed data were interpreted using Kruskal - Wallis 
ANOVA.  Differences in means among treatment periods were compared using Dunn’s test.  
Student’s t-test was used to compare differences in the timing of ovulation between treated 
and naturally-cycling mares.  One-way ANOVA of mean urinary hormone concentrations






between treatment periods (pre-, peri-, and post-treatment) was used to evaluate the impact of 




When comparing three ovulatory agents, two mares received two treatments and one 
mare received all treatments. Mares at the Wilds only received one treatment (GnRH) and 
did not respond and were not assessed after one trial.  There were no significant differences 
in the interval between the time of injection and ovulation among ovulatory agent treatment 
(i.e., GnRH and reLH) and control (Figure 3.3). For the one mare that received all 
treatments, the days for each treatment were: 1) reLH, 3 days; 2) GnRH, 4 days; and 3) 
saline, 5 days.  The mare that received all treatments was also the only mare to ovulate 
normally with all treatments.  The other mares formed luteinized follicles when treated with 
reLH (n = 1) and GnRH (n = 2). 
Endocrine Response:
Because ovulatory agents had no effect on ovulation interval, data from all mares were 
combined to assess the efficacy of oral altrenogest therapy on estrous cycle management.  
Mares at SCBI (n = 3) received three treatments with altrenogest (n = 9 treated cycles) and 
mares at the Wilds (n = 2 treated cycles) received only one treatment of altrenogest (n = 2).
Average ovarian steroid concentrations during the three treatment periods (pre, peri, and 
post) are shown in Figure 3.4.  While there was no significant change in mean urinary 
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Figure 3.3: Days from treatment to ovulation in Przewalski’s mares (n = 5) treated 
with saline (n = 2); GnRH (n = 5) and reLH (n = 2).  Data are shown as means and 
error bars depict SEM.  There was no significant difference detected between 
treatments (P > 0.05).
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Figure 3.4: Mean urinary hormone levels for during treated cycles (n = 9) of Przewalski’s 
mares with 14 days oral altrenogest.  Data are shown as mean " SEM and difference between 




























estrogen metabolite levels among the three periods, there were differences in mean 
concentrations of urinary progestagen metabolites between pre- and peri/post-treatment (P < 
0.05).  
Of the 11 treated cycles, levels of urinary estrogen and progestagen metabolites were 
below baseline in five (45.4%) trials before altrenogest treatment onset.  Four mares (80%) 
excreted baseline hormone concentrations during the treatment period.  Urinary estrogen and 
progestagen excretion during the remaining six treated cycles were above baseline before 
altenogest administration, but hormone concentrations  in four of the six mares (67%) 
declined to below typical baseline concentrations within 6.3 " 1.2 days of treatment 
(estrogen: 5.7 days; progestagen: 7.5 days).  Overall, urinary steroid hormone excretion was 
below baseline by the end of treatment in 9 of 11 cycles (91%).
Although estrogen and progesterone production appeared to be suppressed in the majority 
of the altrenogest-treated mares, there was wide among-female variation in hormonal 
response to treatment.  Figure 3.5 depicts the overall mean response for all 11 treatments, 
whereas mean urinary hormone profiles for Przewalski’s mares that received three treatments 
(n = 3 mares) are presented in Figure 3.6.  Mare 1 exhibited a gradual increase in urinary 
estrogens near the end of the treatment period.  There was wide variation in urinary 
progestagen excretion during treatment for this mare, which ovulated once during the 
treatment period.  Mare 2, a mare that did appear to respond to two of three treatments, 
unexpectedly excreted increased urinary progestagen metabolites during the treatment period.
Mare 3 excreted increased urinary estrogens during the late treatment period, but did not 
ovulate until after therapy was completed. 
84
Figure 3.5:  Longitudinal urinary hormone data for n = 11 cycles from Przewalski’s mares 
treated with 14 day oral altrenogest.  Gray area depicts treatment period.  Data are shown as 
Mean " SEM.
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Figure 3.6: Longitudinal urinary hormone profiles for Przewalski’s mares (n = 3) treated 
with 14 day oral altrenogest.  Gray area depicts treatment with altrenogest.  Graphs depict the 






Follicular changes also showed wide variation in response to oral altrenogest therapy.  Of 
the 11 cycles monitored, two (18.2 %) ovulations occurred during treatment. In four cycles, 
a follicle > 30 mm was detected at initiation of treatment and three (75%) of these follicles 
regressed by the end of treatment. After treatment, 6 of 11 treated cycles (54%) exhibited 
normal estrous follicle development and ovulation 4.4 " 0.8 days after treatment was 
completed.  In contrast, luteinized follicles or no estrus was observed in 27% (3/11 cycles) 
and 9% (1/11 cycles) of estrous cycles, respectively.
Endocrine Response:
Study 2
Table 3.1 shows mean hormone levels for pre-, peri-, and post-treatment for both oral 
(O12) and injectable (In12) altrenogest therapies. There was a significant difference in mean 
urinary hormone concentrations among groups before (P < 0.05) but not after altrenogest
treatment (P > 0.05).  During treatment, mean urinary estrogen and progestagen metabolites 
were significantly lower (P < 0.05) in mares treated with injectable altrenogest (estrogen:
28.2 " 2.5 ng/mg Cr; progestagen: 16.6 " 4.1 ng mg Cr) compared to mares treated with oral 
altrenogest (estrogen: 43.1 " 3.8 ng/ mg Cr; progestagen: 37.5 " 4.9 ng/mg Cr). Figure 3.7 
shows longitudinal urinary hormone data for mares in O12 and In12 treatment groups.
Urinary estrogen excretion at the time of treatment onset exceeded baseline in three of 
five mares (60.0%) treated with oral altrenogest (O12). Urinary estrogen and progestagen 
excretion declined below baseline 3.0 " 0.6 days and 5.0 " 0.7 days after the initiation of the 
treatment, respectively. Before treatment onset, four of the five mares (80.0%) treated with
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Table 3.1: Mean urinary hormone concentrations during pre-, peri- and post-treatment 
periods.  Data are presented as mean ± SEM and were compared among treatment periods.  
Injectable altrenogest showed a significant difference compared to oral altrenogest during the
pre- and peri- treatment periods (P < 0.05).  Significance is depicted by (*).
oral altrenogest (O12) excreted urinary progestagen concentrations that exceeded baseline; 
steroid concentrations fell below baseline 4.2 " 0.7 days later (4/4 mares, 100%).
A total of 11 cycles were evaluated in six mares treated with injectable altrenogest (In12; 
n = 6 mares).  Urinary estrogen and progestagen excretion was below baseline prior to 
therapy in 72.7% (8 of 11 cycles) and 81.8% (9 of 11 cycles), respectively. Of estrous cycles
characterized by below baseline hormone concentrations before treatment onset (n = 8
cycles), urinary estrogen excretion increased 9.3 " 0.7 days after altrenogest injection. In
contrast, urinary progestagens were lower than baseline at the time of altrenogest 
administration in nine cycles, and progestagens exceeded baseline in only a single instance (8 
days after altrenogest injection).  Overall, urinary hormone excretion was below baseline 




Treatment Pre Peri Post Pre Peri Post 
Oral Altrenogest 12 D 59.3 ± 5.0 43.1 ± 3.8 62.4 ± 9.2 56.0 ± 8.0 37.5 ± 8.0 28.3 ± 4.2
Injectable Altrenogest 43.9 ± 2.3 * 28.2 ± 2.5 ** 52.8 ± 4.3 21.2 ± 9.7 * 16.6 ± 4.1 * * 18.2 ± 7.8
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Follicular Response:
All mares treated with oral altrenogest (O12, n = 5 mares) had a CL present on the ovary 
at the initiation of treatment.  Of five mares treated with injectable altrenogest, four (In12; 
80%) had an active follicle present at the initiation of treatment (Mean: 37.5 " 5.6 mm;
Range: 25 – 50 mm).  All follicles noted at the initiation of treatment regressed, and one of 
five (20%) mares developed a new follicle and ovulated during the treatment interval.  Of the 
five mares treated with the oral altrenogest, one (20%) ovulated during treatment.  During the 
second year (2009, n = 5 mares), all mares were treated with injectable altrenogest and 
ultrasound examinations were not performed prior to treatment. One of the six mares 
(16.6%) ovulated during treatment period, based on the presence of active CL detected after 
therapy and increased urinary progestagen metabolites during treatment period.  
Overall, four or five mares (80%) treated with oral altrenogest developed an estrous 
follicle in 82% of cycles (9/11 cycles).  Estrous follicles were detected in 83% (5/6 mares) of 
mares treated with injectable altrenogest.  There was no significant difference between 
treatment and days to detection of dominant follicle (O12, 2.4 " 0.9 days; In12, 2.3 " 0.6
days; P > 0.05).
Ovulation Induction:
Figure 3.7 shows the difference between mares treated with GnRH compared to natural 
cycles from our previous study (n = 10 mares).  These data revealed a significant difference 
in the number of days to ovulation between treated and untreated mares (Treated, 2.1 " 0.1
days; Untreated, 9.9 " 0.7 days; P < 0.05).  Mares in the present study were treated with 
GnRH when follicle size averaged 39.0 " 1.6 mm (Range, 31 – 43 mm) and ovulated at 2.1 "
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Figure 3.7: Days from detection of estrus follicle to ovulation in Przewalski’s mares 
(n = 10) that had no treatment (natural cycle) and were treated with ovulatory agent (GnRH).  
There was a significant difference detected between groups (P < 0.05).
0.1 days post –treatment (Range, 2 – 3 days).  Because mares were involved in an AI trial, 
two mares received two injections of GnRH in year 2 of the study.  Because these mares 
failed to respond to the first dose of GnRH, a second dose administered 2 days later resulted 
in subsequent ovulation within 48 hours.  All mares had uterine edema present at time of 
treatment (Range, slight – Grade 3). Of the ten mares treated over the two study periods, 
only one (10 %) showed no evidence of ovulation within four days of treatment.  Urinary 
progestagen metabolites post- induced ovulation remained elevated for 13.5 " 0.8 days 
(Range, 11 – 17 days), which is comparable to the luteal phase duration documented 
previously (11.0 " .09 days; range: 9 – 11 days; Chapter 2).
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Comparison of Treatments:
Table 3.2 shows mean urinary hormonal data for all treatments: oral 14 day (O14), oral
12-day (O12) and injectable 12-day (In12).  There was no significant difference between 
mean hormone levels when comparing 12 - day to 14 - day oral treatments.  However, 
urinary hormone concentrations in the injectable altrenogest group were different (P < 0.05) 
compared to the other treatments during both the pre- and peri-treatment periods . 
There was no significant difference (P > 0.05) in days from completion of therapy to 
detection of a dominant follicle among treatments (O14, 4.4 " 0.8 days; O12, 2.4 " 0.9 days; 
In12, 2.2 " 0.6 days).  Treatment 1 (O14) had the lowest response post-treatment with only a
54.5% (6/11 treated cycles) normal response.  These response rates were lower (P < 0.05)
than the 80% (4/5 cycles) and 82% (9/11 cycles) levels observed in the O12 and In12 
protocols.  Ovulation was detected in 18% (2/11 cycles) of the O14, which was similar to the 
20% (1/5 cycles) and 18% (2/11 cycles) ovulation rates detected in the O12 and In12 
treatment groups.  Luteinized follicles or no treatment response was observed in 27% (3/11 
cycles) and 9% (1/11 cycles), respectively, of the O14 regimen.
Treatment during the Follicular vs. Luteal Phase
To determine whether stage of the estrous cycle impacted treatment outcomes, data were 
also analyzed based on whether treatment was initiated during the follicular or luteal phase.  
For treatment 1 (O14), 36% (4/11 cycles) were initiated during the follicular phase.  Of these, 
50% (2 of 4) resulted of treatments were successful in suppressing ovulation.  Similarly, 51% 
(4/7 cycles) of treatments initiated during the luteal phase were successful at suppressing 
ovulation.
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Table 3.2: Mean urinary hormone concentrations during pre-, peri- and post-treatment 
periods.  Data are presented as mean ± SEM and were compared among treatment periods.  
Injectable altrenogest showed a significant difference compared to other treatments during 
the pre- and peri- treatment periods (P < 0.05).
Treatment 2 (O12) was initiated in all mares (n = 5) during the luteal phase, and one
(20%) did not respond to treatment.  For treatment 3 (In12), 36% (4/11 cycles) were initiated 
during the follicular phase.  Fifty percent (2/4) of treatments initiated during the follicular 
phase were successful in suppressing ovulation, whereas 86% (6/7) of treatments 
administered during the luteal phase were successful. When all treatments (O14, O12, In12) 
were combined, altrenogest administered during the follicular phase was associated with a 
50% (4/8 cycles) incidence abnormalities, including hemorrhagic follicles and ovulation 
during therapy.  In contrast, similar abnormalities were observed in only 26% (5/19 cycles) 
of cycles in which treatment was initiated during the luteal phase. 
DISCUSSION
This is the first study to describe successful manipulation of the estrous cycle using 
hormonal therapy in a wild equid species. We demonstrated that altrenogest (injectable and 
oral forms) suppresses ovulation in a majority of mares, and, when combined with PGF2 ,
Estrogen Conjugates Pregnane
Treatment Pre Peri Post Pre Peri Post 
Oral Altrenogest 14 D 76.0 ± 4.9 64.7 ± 7.6 57.1 ± 4.7 35.1 ± 3.9 23.7 ± 1.8 17.5 ± 0.9 
Oral Altrenogest 12 D 59.3 ± 5.0 43.1 ± 3.8 62.4 ± 9.1 56.0 ± 8.0 37.5 ± 8.0 28.3 ± 4.2 
Injectable Altrenogest 43.9 ± 2.3 * 28.2 ± 2.5 * 52.8 ± 4.3 21.2 ± 9.7 * 16.6 ± 4.1 * 18.2 ± 7.8 
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causes reasonable estrous synchrony in Przewalski’s mares.  Similar to the domestic horse, 
altrenogest was more effective in manipulating estrous cycle when initiated during the luteal 
phase.  These data revealed that Przewalski’s mares may benefit from management practices 
commonly used to improve breeding management in the domestic horse industry. 
In most mammals, follicles are recruited from an antral follicular pool during the luteal 
phase when progesterone is produced by the CL (Senger, 2003).  At the end of the luteal 
phase, progesterone levels drop and the increased episodic production of FSH and LH cause 
selection and maturation of the dominant follicle(s), which then leads to ovulation.  By 
mimicking the luteal phase, altrenogest, a synthetic progestagen, postpones the onset of 
follicular development by suppressing LH production from the anterior pituitary until                                                                                                                              
treatment is stopped (Senger, 2003; Soede et al., 2007; Blanchard et al., 2004).  Altrenogest 
has been used successfully for estrus synchronization.  In gilts, 93 – 95% of animals treated 
for 18 days with oral altrenogest exhibit estrus within 5 – 7 days after withdrawal (Martinet –
Botte et al, 1995; Koutsotheodoros et al., 1998; Horsley et al., 2005).  Gilts treated with 
altrenogest develop more follicles (16.6 ± 1.7) after therapy compared to gilts that received 
no treatment (15.1 ± 1.2; Soede et al., 2007).  In the domestic queen, altrenogest therapy 
suppresses follicular activity and a normal follicular phase occurs after 38 days of therapy 
(Stewart et al., 2010).  In wildlife species, altrenogest has also been used with variable 
response.  For instance, in the Pacific white-sided dolphin, 6 females were treated with 
altrenogest for 20 to 30 days over several years.  Of the 57 treatments, only 17 (30%) 
produced a dominant follicle by 15.2 ± 5.5 days (Robeck et al., 2009).  Likewise, in the killer 
whale, treatment with altrenogest resulted in a delay of follicular development after 30 days 
of treatment (Robeck, 2004).  
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In Przewalski’s mares, all treatments of altrenogest were effective for manipulating the 
estrous cycle, although the injectable form and 12 day oral treatment showed better response 
rates compared to the 14-day oral treatment regimen (83.3% and 80% compared to 54.5%).
A high prevalence (3 of 11; 27.3%) of hemorrhagic anovulatory follicles (HAF) was also 
associated with the 14-day oral treatment.  One possible explanation for this observation is 
that this treatment interval exceeds the duration of the normal luteal phase (11.0 " 0.7 days).  
Prolonged progesterone treatment in cattle results in development of persistent ovarian 
follicles and overproduction of estrogen (Ahmed et al., 1994). Similarly, in the domestic 
mare, hemorrhagic follicles are associated with higher levels of peripheral LH compared to 
mares that have normal ovulations (Ginther et al., 2008).  In the domestic horse, cow and pig, 
altrenogest-induced LH suppression is weak.  Thus, the hormonal milieu during the 
prolonged luteal phase in the Przewalski’s mare may have resulted in the development of an
increased number of HAF. Treatment with PGF2 in the domestic horse induces a sudden 
increase in LH that can over stimulate immature follicles, leading to the formation of HAF 
(Cuervo-Arango et al., 2009). However, because HAF were not observed in either of the 
other two treatment regimens (Oral 12 day and Injectable 12 day) that also employed 
PGF2
Treatment with injectable altrenogest was more effective for suppressing ovarian steroid 
excretion during the treatment period.  This may be because the biorelease system achieves
high circulating levels of altrenogest that gradually subside to non-therapeutic levels over the 
12-day period (Burns et al, 2006).  In contrast, oral treatment results in a rapid increase in 
altrenogest within the bloodstream, but hormone concentrations decline rapidly within the 
 , we speculate that the length of altrenogest treatment was likely to have resulted in 
increased numbers of HAF.
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subsequent 12-24 hours; in some individuals, levels may even drop to non-therapeutic levels.
Przewalski’s mares demonstrated a response rate of 83.3 % (Injectable) and 80.0% (Oral 12
day), with estrus occurring 2.2 " 0.54 (Range, 1 – 5 days; Injectable-12 day) and 2.4 " 0.9
days (Range, 2 – 4 days: Oral-12 day) post - treatment. In constrast, response rates to the 
Oral-14 day treatment was 54.5%, with estrus occurring 4.4 " 0.8 days (Range, 2 – 7 days).
These results are comparable the domestic horse, whereby 80% of mares exhibit estrus 2 – 8
days after cessation of a 10-15 day oral altrenogest treatment regimen (Bergfelt, 2000).
Altrenogest administered during the first three days of the follicular phase significantly 
lowered the response to treatment (Squires, et al., 1979; Lofstedt, et al., 1989).  This may be 
related to the fact that altrenogest only binds to receptors on the anterior pituitary with 60% 
of the binding affinity of natural progesterone, which results in incomplete suppression of LH 
secretion (Hughes et al., 1972). In the present study, altrenogest treatments that commenced 
during the follicular phase resulted in a 50% response rate compared to 79% percent for 
treatments initiated during the luteal phase.  These results provide incentive for additional 
research to better understand the relationship between altrenogest treatment and the dynamics 
LH secretion in the Przewalski’s mare.  
Prostaglandins (PGF2 ) administered within 5 days of ovulation have been used to 
effectively induce luteolysis in the Przewalski’s mares (Durrant et al., 1986).  In the current
study, PGF2 administration coincident with the cessation of progestagen therapy appeared 
to shorten the interval to estrus.  Evidence for this included an absence of luteal tissue after 
treatment, as well as basal concentrations of urinary progestagen metabolites (20/26 mares, 
77% overall) by the end of treatment and in 14 of 16 mares (87.5%) that received the 12-day 
altrenogest regimens (injectable and oral). Additional research should focus on comparing 
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altrenogest treatment with and without prostaglandins to determine which approach is most 
effective for achieving estrus synchrony.
Ovulation is a complex process that is induced by an increase in LH.  The length of time 
from estrus to ovulation varies in many species from 15 hours (cow) to 9 days (bitch) 
(Senger, 2003).  In the domestic horse, the length of estrus ranges from 2 – 12 days, 
depending on the time of year, and ovulation usually occurs 48 hours before the end of 
estrus, which makes ovulation timing difficult to predict (Palmer, 1978; Ginther, 1993; 
Blanchard et al., 2003).  For AI to be successful, semen needs to be deposited in the uterus 
within 12 – 24 hours of ovulation (Samper, 2008).  In many species, ovulatory agents are 
used to enhance AI success. To date, only one study has tested the efficacy of an ovulatory 
agent, hCG, in Przewalski’s mares (Durrant et al., 1986).  When hCG was administered 7
days after PGF2 treatment ovulation did not occur within the subsequent 24 hours.  Because 
hCG can take 24 – 48 hours to induce ovulation (Blanchard et al, 2003; Palmer et al., 1993),
failure to detect ovulation may have been due to the inability to examine mares daily due to 
anesthetic risk. While we were unable to determine a difference between reLH, GnRH and 
controls in the first study, in a subsequent study in which mares were treated with 12 days of 
altrenogest, we were able to determine a difference between days from detection of an 
estrous follicle to ovulation in natural cycles compared to cycles treated with a GnRH 
agonist.  A significant difference (P < 0.05) was detected between length of time from 
gonadotrophin administration to ovulation between treated mares (2.12 ± 0.12 days) and 
untreated mares (9.87 ± 0.72 days).  These data revealed that the GnRH agonist, deslorelin,
was effective for shortening the time to ovulation, achieving treatment responses that were 
similar to the domestic mare. Most importantly, the post-treatment luteal phase was similar in 
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length to the luteal phase in untreated cycles, which indicated that induced that ovulations 
produced apparently normal CLs.
Previous studies in the domestic horse have shown that responsiveness to altrenogest 
varies depending on the reproductive stage at the time of treatment initiation (Lofstedt, 1988; 
Squires, 1979). In one study, only 1 of 4 mares treated with altrenogest during the follicular 
phase ovulated because altrenogest treatment during the follicular phase did not appear to 
shorten the CL life span (Lofstedt, 1989). In gilts, there is an increase in number of follicles 
produced when altrenogest therapy is initiated during the late luteal phase. One theory is that 
the high level of endogenous progesterone production during the luteal phase effectively 
suppresses follicular development, which is then extended by altrenogest therapy (Soede, 
2007).  This is consistent with the present study as there was a decreased response rate in 
mares treated with altrenogest during the follicular phase, even among treatments.  
This was the first study to assess estrous synchronization in Przewalski’s mares using a
combination of altrenogest and PGF2 . We also demonstrated that GnRH effectively 
induced ovulation in when large ovarian follicles (>31 mm) and uterine edema were present
in treated mares.  Although ultrasound examination is still necessary to predict presence of an 
estrous follicle, we confirmed that injectable altrenogest, in combination with PGF2 , has 
tremendous potential for optimizing AI for genetic management in this endangered species.
Additional studies focused on optimizing ovarian synchrony are necessary for the 
development of reliable fixed time AI with high conception rates.
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CHAPTER FOUR
Characterization of Seminal Traits in Przewalski’s Stallions
INTRODUCTION
The Przewalski’s horse (Equus ferus przewalskii) is the last of the wild horses, 
native to China and Mongolia.  With only 1500 animals remaining in captivity and no 
new founders in the wild, genetic management is a key for long-term maintenance of this 
species.  The captive population of Przewalski’s horses in North America is currently 
managed by the Asian Wild Horse Species Survival Plan (SSP).  Each year, breeding 
recommendations are made based on mean kinship values of mares and stallions in the 
captive population.  After recommendations are made, mares or stallions must then be 
moved to the designated zoological institutions which can be expensive and risky to the 
animals being shipped. Because of this, zoological parks are less interested in movement 
of animals, which can result in failure to breed genetically valuable animals.  
Poor breeding management and loss of animals in the wild have lead to increased 
inbreeding in the population of Przewalski’s horses.  In the SSP population, the 
coefficient of inbreeding is 0.216 with a gene diversity of 78.55% (Monfort et al., 2009).  
It has been shown that reproduction can be compromised when the gene diversity is 
below 90% (Monfort et al., 2009).  Breeding recommendations from the SSP have 
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established 40 breeding pairs over the last five years, with only 8 foals produced on 
average each year (20%).  This low foaling rate indicates that poor reproduction is a 
potential threat to the sustainability of the captive population of Przewalski’s horse in 
North America.  Studies in other ungulate species show that, seminal parameters, such as 
morphology and motility, and reproductive fitness are negatively affected by increasing 
homozygosity (Ralls et al., 1979; Rolden et al., 2006; Fitzpatrick and Evans, 2009). A
recent study in Shetland pony stallions has shown a decrease in motility and percentage 
morphologically normal sperm when the coefficient of inbreeding was greater than 2% 
(van Eldik et al., 2006)
Artificial insemination (AI) has been used as a breeding management tool for 
genetic management of wildlife species such as the Giant panda (Ailuropoda 
melanoleuca; Hori et al., 2006), black-footed ferret (Mustela nigripes; Howard et al., 
2003) and Asian elephant (Elephas maximus;  Brown et al., 2004; Hildebrandt et al, 
2000). While this procedure has been successful in some species, a foundation of basic 
reproductive physiology for each species, including characterization of seminal traits,
was needed before AI could be incorporated into a management program.  To date, there 
is limited information on semen parameters in Przewalski’s stallions.
In the domestic stallion, semen evaluation is performed to: 1) predict the potential 
fertility of a given stallion and 2) determine whether a stallion’s semen is able to tolerate 
handling procedures such as cooling or freezing (Blanchard et al., 2003).  Many reports 
confirm that semen parameters in domestic stallions can vary due to individual animal 
variation, age, and season of the year (Johnson and Thompson, 1983; Magistri et al.,
1987; Johnson et al., 1991; Dowsett and Knott; 1996, Jannett et al., 2003, Gamboa et al., 
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2009).  In the Przewalski’s stallion, only limited work – mainly opportunistic and/or 
combined with other medical procedures – has been undertaken to examine semen 
parameters (Stover et al., 1981, Durrant 1990; Bader et al, 1991); and no systematic 
serial semen evaluations have been performed.  This is an important point because, in the 
domestic stallion, a single semen sample does not provide an accurate assessment; it is 
generally accepted that accurate semen assessments require 2-5 sequential collections 
(Blanchard et al., 2003). 
Domestic mares are long-day breeders and have a period of anestrus in the winter 
months (Blanchard et al., 2003; Ginther, 1992).  Stallions produce sperm throughout the 
year; however, effects of season on testicular function in the stallion have been well 
documented.  During the physiological breeding season (May through August), stallions 
produce an elevated amount of sperm (Thompson et al., 1977; Johnson and Thompson,
1983) and testosterone (Hoffman and Landeck., 1999).  Furthermore, it has been shown
that numbers of spermatogonial cells increase in the testis during the breeding season 
compared to the non-breeding season (Johnson, 1985).  Studies on the influence of 
seasonality on sperm motility have shown contradictory results; one study showed 
increased motility during breeding season (Hoffmann and Landeck, 1999), whereas 
another showed a decrease in motile sperm during this period (Blottner et al., 2001).  
There also appears to be differences among horse breeds.  For instance, a study in 
Warmblood stallions showed that volume, motility, total concentration and major 
morphological defects were highest in the summer (Janett et al., 2003).  However, it was 
shown that only total concentration was highest in summer compared to other seasons in 
Franches-Montagnes stallions (Janett et al., 2003). Only one study in Przewalski’s 
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stallions has shown that there is a seasonal effect on seminal traits such as 
morphologically normal sperm, volume and motility (Durrant, 1990).  A total of 21 
semen collections from ten stallions of varying age (2.5 – 22 years) were assessed over a 
12 month period.  Total volume was highest in spring and motility was highest in autumn 
and spring.  While this study was important in characterizing seminal traits and seasonal 
variation in seminal traits in Przewalski’s stallions, semen collections were only 
performed over a 12 month period.  By performing a long-term study on more males, 
seasonality and seminal traits should be more defined.  
Cryo-survival of stallion sperm has been shown to be influenced by seasonality 
(Magastrini et al., 1987; Blottner et al., 2001; Janett et al, 2003; Gamboa et al., 2010).  In 
Franches  - Montagnes and Warmblood stallions, post-thaw quality improved in samples 
collected in autumn.  However, this finding is in contrast to an earlier study in which six 
mixed breed stallions showed improved post-thaw quality when spermatozoa were 
collected in winter (Magastrini et al., 1987).  Since long-term management of 
Przewalski’s horses is reliant on preservation of valuable genetics, understanding the 
influence of seasonality on seminal parameters may indicate the optimal time to collect 
high quality samples for sperm preservation.
Therefore, the objectives of this study were to evaluate semen in Przewalski’s 
stallions (n = 14; 4 – 23 yr old) and compare parameters among males with respect to 
individual stallion effect, season and inbreeding. This knowledge will inform decision 
making related to reproductive management in captive Przewalski’s horses. We 
hypothesize that semen quality will show higher concentration and motility in the 
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Przewalski’s stallions (n = 14; Age: 4 – 28 years) from two institutions 
(Smithsonian’s Conservation Biology Institute (SCBI): n = 7; The Wilds: n = 7) were 
used throughout this study.  Stallions at SCBI were kept in individual paddocks except 
when in breeding situations (n = 1) during which mares were also placed in the enclosure.  
Stallions at the Wilds were kept either in a breeding herd (n = 2) or in a bachelor band.  
Animals were fed herbivore low protein pellets, hay and had access to grass and mineral 
licks.
Semen Collection
Semen collections were performed during four different time periods each year so 
that all seasons were represented.  Seasons were defined as: Spring: Feb22 – June 1;
Summer: June 20 – Sep 20; and Fall: September 21 – December 21; Winter: December 22 -
February).  All stallions from both institutions were collected within a 2-week time period.  
At each collection, stallions were anesthetized using a combination of detomidine 
(Dormosedan
®
, Orion Corp., Espo, Finland), ketamine (Ketaved
®
, Phoenix Scientific, St. 
Joseph, MO), etorphine (M99
®
, Wildlife Pharmaceuticals, Fort Collins, CO), and 
guaifenisin (Guafenisin injection, Phoenix Scientific, St. Joseph, MO).  A standardized 
electroejaculation protocol was used to collect semen (Howard, 1986).  Briefly, a sine-wave 
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electro stimulator (AC, 60-Hz) and Teflon® rectal probe (7 cm; P.T. Electronics, Boring, 
OR, USA) was used to administer 90 incremental stimuli administered in a 3 sec on-off 
pattern in three series consisting of 30 (10 stimulations at 2, 3 and 4 Volts, respectively), 30 
(10 stimulations at 3, 4 and 5 Volts) and 30 stimuli (10 stimulations at 4, 5 and 6 Volts).  
Each series was separated by a 5-min rest interval at which time seminal aliquots were 
assessed.   At the end of each semen collection, a testicular examination was then performed 
by ultrasound (Sonovet 2000, Universal Ultrasound, Bedford Hills, NY, USA).
Semen Evaluation
Raw semen samples from each series were analyzed for volume, pH, osmolarity and 
total motility.  One representative samples from the raw ejaculate (40  L) was fixed in 400 
 L 0.4% gluteraldehyde and stored at 4! C until morphological assessment was performed.  
Semen aliquots were then extended at a 1:4 dilution in skim milk based extender (INRA 96, 
IMV Technologies, Maple Grove, MN, USA) and assessed for percent total motility (%TM) 
and percent progressive motility (% PM) (Blanchard, 2003).  Total progressively motile 
sperm numbers were also calculated for each stallion at each collection.
Morphological Assessment
At least 200 cells were examined by phase microscopy (100 X:  Olympus BX40;
Hunter Valley, PA, USA).  Morphology was determined using the following categories: 
normal cells, head defects, mid-piece defects, proximal cytoplasmic droplets (PCD), distal 
cytoplasmic droplets (DCDs), tail defects, and loose heads.  The number of total 
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progressively motile morphological normal (TPMMN) spermatozoa was then calculated for 
each ejaculate and each stallion. 
Testicular Examination:
Testicles were assessed by digital palpation for any abnormalities in firmness or 
position.  An ultrasound examination was then performed to assess structure of testes and 
the epididymides.  Height and width (mm) of each testicle was then measured using 
ultrasound (Sonovet 2000, Universal Ultrasound, Bedford Hills, NY, USA) and length 
(mm) was measured using testicular calipers. Testicular volume for each testicle (TV) 
was then calculated using the formula for an ellipsoid structure (TV (mm 
3
) = 4/3 "
((height x width x length)/2); Love, 1991).  Total testicular volume (TTV) was calculated 
by adding TV for both right and left testicles together.  Estimated Daily Sperm Output 
(EDSO) was then calculated using the formula: EDSO (billions of sperm/day) = (0.024 x
TTV) – 1.26 (Blanchard, 2003).
Statistical Analysis
Seminal traits (concentration, pH, osmolarity, motility, extended motility, 
progressive motility, normal morphology, total testicular volume, and total progressively 
motile sperm) were compared by Analysis of Variance (ANOVA) by using PROC GLM 
(SAS, Version 9.2, Cary, NC, USA).  To achieve normal distribution, data presented as 
percentage (motility, extended motility and progressive motility) were transformed using 
the formula: Log (100 – value).  Stallion was set as the random effect, which corrected 
for the correlations between records of the same stallion.  Fixed effects, included in the 
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model were season and year of collection. Age and genetics were not assessed due to the 
fact that these traits were heavily confounded with the stallion.  
Due to the high variations in season, this effect was compared two ways: 1) 
standard season by comparing means; and 2) continuous variation throughout the year.
Continual variation was assessed according to Fireman el al. (1997).  Briefly, Julian dates 
were generated for each collection day (January 1 = day 1, December 31 = day 365) and 
then converted to radians (January 1, y = 0 radians, December 31, y = 2p radians). The 
trigonometric functions sine and cosine were applied to the measurements in radians 
corresponding to the collection days. The measures sin (y) and cos (y) allow detection of 
a yearly pattern (wave) in the dependent variables, with one peak (maximum value) and 
one valley (minimum value). In addition, the semi-annual wave was studied by using sin 
(2y) and cos (2y), which allows detecting important departures from the annual wave 
(e.g., two annual peaks or a seasonal plateau). The sine and cosine values were then used 
as independent variables in a covariance analysis. Significance was verified by t-tests 
since the independent variables were orthogonal and a regression coefficient was 
estimated for each sine and cosine regressor (Fireman et al., 1997). Predicted values 
were obtained using the mean value of the trait as the intercept and adding to that the 




A total of 98 semen collections were performed from September 2005 – June 
2009 on Przewalski’s stallions (n = 14) and semen samples were obtained in 86 
collections (87.8 %).  Semen parameters averaged from all collections are shown in Table 
4.1.  There was a large amount of variations among stallions in seminal traits, including 
volume, concentration, motility and progressive motility.  Semen samples obtained in the 
present study contained large proportion of sperm with abnormal morphology (80%; 
Table 4.2).   The majority of structural abnormality was defects to the head of the sperm, 
including folded acrosome, crater defects, size and shape of head (Figure 4.1) 
Testicular Examination
Testicles were examined at all collections and of the 14 stallions examined, one
stallion (7.1%) was cryptorchid.  On ultrasound, testicular parenchyma was fairly 
homogenous with a central testicular vein noted (see Figure 4.2).  The cauda epidiymis 
was readily visible at the caudal pole of each testicle.  In all examinations, no rotation of 





Table 4.1:  Seminal parameters for 14 Przewalski’s stallions collected over a 
45 month period.  Data are presented as Mean ± SEM.
Variable Mean ± SEM
Volume (mL)                         
(n = 92)
31.15 ± 2.14
pH                                       
(n = 91)
9.2 ± 0.03
Motility (%)                          
(n = 86)
42.24 ± 2.27
Extended Motility (%)            
(n = 85)
61.78 ± 1.76





)              
(n = 86)
2.69 ± 0.27
Normal Morphology (%)           
(n = 56)
19.13 ± 2.70
Age at Collection (years)        
(n = 94)
14.36 ± 0.65
Osmolarity (mOsm)               
(n = 82)
299.75 ± 2.76
Total Testicular Volume      
(n = 63)
212.31 ± 6.87 cm
3
TPPMN                       
(n = 56)




Normal 19.13 ± 2.70
Head Defect 27.09 ± 2.80
Mid - Piece Defect 17.81 ± 2.87
Proximal Cytoplasmic Droplet 21.04 ± 2.98
Distal Cytoplasmic Droplet 14.38 ± 1.58
Tail Defect 2.38 ± 0.45
Round Cell 0.83 ± 0.20
Other 2.63 ± 1.91
Table 4.2: Sperm morphology for Przewalski’s stallions (n = 56 samples).  Data 
are presented as mean ± SEM.
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Figure 4.1: Two spermatozoa with folded acrosomes (depicted by arrow).  Spermatozoa 
were examined by phase microscopy at 100X.
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Seasonal Effects
The results from ANOVA (Table 4.3) clearly demonstrate that the effect of 
stallion has a significant influence on all parameters except seminal pH (P < 0.05).  
Seasons did not affect seminal traits (P > 0.05) except volume and pH (P < 0.05).  There 
were definite variations among individuals in total concentration (Figure 4.3), progressive 
motility (Figure 4.4), normal morphology, TTV (Figure 4.5) and total progressively 
motile sperm.
Figure 4.2: Ultrasound of testicle during examination of a Przewalski’s stallions.  Image 
shows cross section of testicle from the ventral aspect of the scrotum.  This image shows 
height (mm) being measured (52mm).
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Variable Seasonal Effects:
Due to the high variation detected in seminal traits, over seasons, analysis was 
performed to determine whether there was continual variance in seminal traits.  Table 4.4
shows that level of variation in seminal traits and significance for variable factors (sine, 
cosine, 2* sine, 2*cosine).  Seminal traits that showed a high coefficient of variation were 
normal morphology, volume and concentration.  Volume and pH were also analyzed 
because season had shown a significant effect on these values.  Volume showed 
significance with independent variable cosine (P< 0.05), which indicates one wave in 
variation in relation to the Julian calendar (Figure 4.6).  Interestingly, the variable curve 
shows a similar pattern to the mean values detected at each season, with peaks in spring 
and summer.  Normal morphology showed significance with independent variable sin*2 
(P < 0.05), which indicates that there are two waves in variation during the Julian 
calendar year in summer and winter (Figure 4.7).  In this case, the curve is more variable 
than the mean values for each season.  Concentration had a trend towards two waves in 
variation (cosine*2). However, due to a high coefficient of variation (80.25), 
this may be a true trend that is not detectable at low numbers (Figure 4.8).  When 
comparing mean values for each season, the trend is similar to the variable predicted 
pattern based on cosine*2.
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Table 4.3: Seminal Traits of Przewalski’s stallions (n = 14) in relation to variables 






Extended Motility 0.0012 0.9866
Progressive Motility 0.0002 0.9374
Concentration 0.0071 0.6225
Normal Morphology <.0001 0.1928
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Figure 4.3: Total sperm concentration (x 10 
9
) of Przewalski’s stallions (n = 10) 









































Figure 4.4: Progressive motility (%) over seasons in Przewalski’s stallions (n = 10).
































Figure 4.5: Total Testicular Volume over season in Przewalski’s stallions (n = 10).
Total Testicular Volume Over Seasons (n = 10 stallions)
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Table 4.4: Seminal traits of Przewalski’s stallions (n = 14).  Column 1 shows 
significance of season on each trait.  Column 2 shows the coefficient of variation.  
Column 3 shows the significance of the variable sine, cosine, sine*2, or cosine*2.
Variable Season Coefficient of Variation Variable 
Volume 0.001 49.939 0.004
pH 0.004 3.711 0.012
Motility 0.4753 7.292
Osmolality 0.0601 7.404
Extended Motility 0.9866 8.616
Progressive Motility 0.9374 6.691
Concentration 0.6225 80.25 0.143
Normal Morphology 0.1928 34.979 0.061
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Figure 4.6: Variable volume of Przewalski’s stallions (n = 10) compared to actual 
mean values at each season.  Predicted values are shown by line and actual means are 
depicted by bars.
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Figure 4.7: Predicted variable change in percentage morphologically normal cells (red 
line).  Detected mean values for each season (n = 14 stallions) are shown by bars.  Line 
shows expected data based on variable analysis.
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Figure 4.8: Predicted variable change in total sperm concentration in Przewalski’s 
stallions (n = 14).  Variable change is shown by line and actual mean values for each 
season are shown by bars.
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DISCUSSION
This is the first study to assess seminal traits and testicular changes in 
Przewalski’s stallions over a two – year period.  Eighty-nine semen samples from 
fourteen stallions were assessed to detect any seasonal changes.  Our results indicate that 
there was high variation in seminal traits among stallions, which has made it difficult to 
clearly determine seasonality in most seminal traits.  Because of this high variation, 
variable analysis methods were applied and showed that there were, in fact, seasonal 
variations in some seminal traits throughout the calendar year.
Prior to this study, there were limited reports on seminal traits in Przewalski’s 
stallions. One study (Bader et al., 1991) evaluated seminal traits in stallions that were 
considered sub- or infertile.  Five stallions were collected by either electro-ejaculation (n 
= 10 collections) or by artificial vagina (n = 30 collections).  One stallion was aspermic in 
all 5 semen collections using both techniques.  In the present study, only one stallion 
(7.69%) failed to produce sperm after 4 attempts at semen collection. While several 
aspermic collections may indicate lack of spermatogenesis for an individual stallion, we 
were unable to collect semen from a stallion that produced several foals, indicating a 
potential issue with collection technique. Comparison in seminal parameters between 
samples collected from two Przewalski’s stallions using artificial vagina vs. 
electroejaculation showed that the former technique yielded higher sperm concentrations 
(6.72 ± 3.0 vs.0.48 ± 0.26 x 10
9 
spermatozoa) and volume (34.5 ± 11.8 vs. 18.0 ± 7.5 mL) 
than the latter (Bader et al, 1991), which had a 52% decrease in volume; a 90% decrease 
in sperm concentration; and a 17.5% increase in morphological defects when comparing 
samples collected by electro-ejaculation to samples collected by artificial vagina (Bader, 
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et al., 1990).  While electro-ejaculation is used in many species, there is still the 
possibility that this collection method may influence seminal parameters overall. Electro-
ejaculation has been used extensively in non-domestic species and most species respond 
by producing seminal fluid containing spermatozoa (Howard et al., 1986).  
Unfortunately, for many of these species, normal ejaculates have not been defined; 
therefore it is difficult to determine whether there is a real difference in seminal traits 
collected by electro-ejaculation compare to natural methods.  For instance, in men, where 
electro-ejaculation is used to collect semen in paraplegic individuals, there are studies 
that state that there are damaging effects to sperm motility (Linsenmeyer et al. 1989; 
Sikka et al.,1994) and others that state that there is no effect on seminal characteristics in 
men (Hovav et al., 2002) or dogs (Ohl et al., 1994).  Spermic sample can also be 
influenced by technique.  In rams, the ejaculatory response is significantly affected by 
duration of stimulation and rest periods (Martin, 1986).  Unfortunately, semen collection 
by electro-ejaculation has been unsuccessful in the domestic stallion (Cary et al., 2004), 
so there is little information that could indicate a difference between collection 
techniques in equid species.  Therefore, it remains possible that variation in seminal traits 
may have been caused by electro-ejaculation. 
It was noted that there was a wide variation in sperm concentrations within and 
among individuals (Range: 0.56 – 16.8 x 10 
9
spermatozoa/ collection).  This is similar to 
that reported in previous studies, in which total sperm concentration ranged from 0.48 –
7.18 x 10
9 
spermatozoa (Bader et al, 1991).   In the domestic stallion, a wide range of 
total sperm numbers has also been observed among individuals (4 to 12 billion in a 
mature stallion; Blanchard et al., 2003).  Lower total numbers of spermatozoa in 
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Przewalski’s stallions may also be a species characteristic as there has been variation in 
domestic stallions based on breed such as the Warmblood (Range: 9.5 – 10.6 x 10
9 
spermatozoa; Jannett et al.,, 2003), the Frances-Montagnes (Range: 5.4 – 8.3 x109
spermatozoa; Jannett et al., 2003), the Throughbred (Mean: 5.03 ± 0.01 x 109; Dowsett 
and Knott, 1996), and the pony (Mean: 1.12 ± 0.04 10
9
; Dowsett and Knott, 1996).
Based on mean TTV (212.31 # 16.87 cm
3
) for the population of Przewalski’s stallions, 
the EDSO should be 3.49 x 10
9
spermatozoa/ collection, which is higher than the actual 
sperm output for all semen collections (2.69 # 0.27 x 10
9
spermatozoa).  The EDSO is 
also lower than TTV and EDSO recorded in the domestic stallion (Johnson and 
Thompson, 1983; Blanchard et al., 2003). Specifically, TTV of domestic stallions (n = 7; 
mixed breeds) 13-20 years of age is 306 mm
3
, which would result in an EDSO of 5.74 x 
10
9
spermatozoa/ day (Johnson and Thompson, 1983).  However, a more recent study 
(Dowsett and Knott, 1996) states that actual DSO for stallions that were 14 years of age 
(n = 81; mixed breeds) was 3.25 # 0.03 x 10
9
Data from the present study indicates that motility is higher for this population of 
stallions compared to those reported in previous studies (Bader et al., 1991; Durrant, 
1990), although previous studies do no indicate whether motility was assessed in 
extended or raw samples.  Assessing motility in raw samples can be unreliable because 
sperm cells may agglutinate, causing the overall motility to be lower (Malmgren, 1997).   
Extending semen also reduces the influence of sperm concentration and pH, which was 
slightly basic in this study (mean, 7.72 # 0.29).  In the current study, there was an 
spermatozoa, which is lower than EDSO 
calculated in previous study, indicating a possible actual decrease in sperm production in 
aged stallions.
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improvement in motility in extended samples (61.78 # 1.76%) compared to the raw 
ejaculates (42.24 # 2.27%).  Again, there was a wide range in motility parameters within 
and among stallions (Range, 0 – 85% motility).  This variation is similar to motility seen 
in other studies conducted on Przewalski’s stallions.  For example, Bader et al. (1991) 
observed sperm motility from 5 – 73.5%, and Durrant et al. (1990) observed sperm 
motility from 15 – 56%.  
In the domestic stallion, the relationship between sperm motility and fertility are 
contradictory.  In many studies, percentage of motile spermatozoa did not influence 
overall stallion fertility (Dowsett and Knott, 1982; Voss et al., 1981).  However, it has 
been shown that the subjective appraisal of progressively motile sperm has a high 
correlation with stallion fertility (Jasko, 1992).  In our present study, percentage 
progressively motile sperm in the Przewalski’s stallion was 52.1 # 1.7 %, and there were
wide variations among individuals (0 – 78.75%).  Overall, based on these data, 
progressive motility assessed in this study is comparable to that of the domestic stallion 
despite the different methods used (Jasko, 1992; Gambo et al., 2009; Blanchard et al., 
2003).
Sperm morphology has become an important parameter for assessing overall 
semen quality associated with fertility (Jasko, 1992; Malmgren et al, 1997), because 
disturbances in spermatogenesis give rise to many morphological defects.  This study has 
shown that there are a very high number of morphologically abnormal spermatozoa in 
this group of Przewalski’s stallions (mean, 19.13 # 2.70 %; range, 10 – 77%).  This is 
much higher than numbers observed in the previous study (range, 38.3 – 52.3%; Bader, et 
al, 1991).  The difference between the two studies may be due to the difference in 
123
stallions and in number of observations (56 vs. 32) as well as observer subjectivity.  
However, overall numbers did not differ significantly from our initial reports conducted 
in nine Przewalski’s stallions housed at three different institutions (Normal = 23.4 # 2.7% 
morphologically normal spermatozoa; Collins et al, 2006). In the domestic stallion, a 
wide range of morphological sperm abnormalities may be acceptable for fertile stallions 
and the effects of specific morphological sperm abnormalities on the fertility of stallions 
has not yet been fully elucidated (Malmgren et al., 1997), mostly due to conflicting
findings.  Jasko (1990) and Morrell et al., (2009) demonstrated that sub or infertility was 
linked to sperm structural morphology, while others showed no relationship between the 
two parameters (Dowsett and Knott, 1982; Voss et al., 1981).  Jasko et al. (1992) 
performed the most comprehensive study of the relationship between semen quality 
parameters and fertility, and found reasonable correlations between percentages of 
progressively motile (r = 0.46) and morphologically normal (r = 0.36) sperm and fertility.  
As a result, the horse industry combine morphological data and motility into a single 
parameter, total progressively motile morphologically normal (TPMMN) 
spermatozoa/ejaculate, as a tool to assess potential fertility in the domestic stallions 
(Hurtgen, 1992; Blanchard et al., 2003).  Based on data collected, the TPMMN 
spermatozoa in this population of Przewalski’s stallions is 0.74 # 0.16 x 10
9
.  This is 
lower than the acceptable level used in assessing the domestic stallion (1.0 x 10
9
TPMMN spermatozoa; Hurtgen, 1992), however, further studies need to be conducted to 
determine whether Przewalski’s stallions that are fertile require the same number of 
TPMMN spermatozoa as the domestic stallion.  
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By analyzing mean values for each season, we were able to detect seasonal 
variation in seminal pH and volume but not in concentration, motility, TTV or normal 
morphology.  Using variable analysis, we were able to show that percentage normal 
morphology is improved in late summer and winter while total concentration is highest in 
late fall and late spring.  Overall, these data indicate that improved sperm quality occurs 
during the breeding season as there is an increase in total numbers and percentage normal 
morphology. We were unable to detect seasonal changes in motility in our analysis.  
These findings differ from those of the previous study by Durrant (1990), which 
evaluated ejaculates from ten Przewalski’s stallions over a 1-year period.  According to 
Durrant’s study, percentage motility was higher in fall and spring and numbers of 
morphologically normal sperm were highest in the winter.  The study also showed that 
total volume was highest in the spring, which was similar to results found in the present
study, although we found no significant difference in total volume between spring and 
summer (P > 0.05).  Our study also found that seminal pH was significantly higher (P <
0.05) in the winter compared to all other seasons. Seminal pH in the domestic stallion is 
influenced by season, frequency of ejaculates, and spermatozoal concentration 
(Blanchard et al., 2003).  More recent research has also shown that levels of the 
proteolytic enzyme, plasminogen activating factor, also vary throughout the year in the 
stallion (Zervos et al., 2010).  While it has not been linked to changes in pH, variations in 
seminal plasma could impact overall pH. 
In the domestic stallion, it has also been difficult to determine whether there is 
seasonality in seminal traits.  Despite the fact that there have been studies describing 
increased daily sperm production in domestic stallions during the breeding season 
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(Thompson et al., 1977; Johnson, 1985), more recent studies have been showing that this 
is not always the case. For example, a study by Janett et al. (2003) states that motility of 
semen samples from Franches-Montagnes stallions is best in winter, spring and summer 
and that percent morphologically normal is highest in the autumn.  However, the lower 
quality sperm traits in the summer are countered by the higher sperm concentration.  A
second study in Warmblood stallions contradicted previous results in that motility and 
total concentration were highest in summer and percentage morphologically normal 
sperm was highest in spring (Janett et al., 2003).  This conflict of defining seasonality in 
the stallion is further confounded by a recent study of spermatozoa from eight stallions of 
varying breeds that showed improved mitochondrial potential, intact acrosomes and 
membrane stability with increasing photoperiod (Gamboa et al., 2010). Interestingly, 
low progressive motility and sperm concentration also occurred with increasing 
photoperiod, indicating that descriptive seminal traits (motility, morphology and 
concentration) are not always indicative of seasonal variation of fertility in stallions.
Because a high level of variation in many of the seminal traits was detected over 
seasons in our current study, analysis was performed to determine whether there were 
variable changes in seminal traits throughout the calendar year that may not have been 
detected in previous analyses.  It was determined that there are variable changes in 
concentration, normal morphology, volume and pH.  Based on variable analysis, our data 
showed some similarities to that of the previous study by Durrant (1990).  Variable 
analysis revealed that morphologically normal sperm were highest in winter and volume 
was greatest in late spring.  Durrant (1990), also described volume as highest in spring 
and morphologically normal sperm were highest in winter.  In the domestic horse, 
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seminal volume is increased from May to August and shows a decrease in the winter 
months (Clay et al., 1987).  The reason for the decrease is still not understood but 
seminal volume is impacted by sexual stimulation, which is increased in the summer 
months (Pickett, 1993).  Also, many stallions will have high sperm output in winter 
months despite lower total ejaculate volume; therefore, total volume is not considered 
important in relation to stallion fertility (Clay et al., 1987).  In the domestic stallion, there 
have been mixed results about when improved percentage morphologically normal sperm 
occurs in the year, but many report improved levels in autumn and/ or winter (Magistrini 
et al., 1987; Blottner et al. ,2001; Jannett et al., 2003). This could be impacted by 
seasonal changes in Sertoli cell population and hormone production in the testes (Johnson 
and Thompson, 1983; Johnson et al., 1991).  Because sperm maturation occurs in the 
epididymis, there are possible seasonal changes in the epididymis that have been reported 
in other seasonal breeders, such as the Roe deer, that may impact maturation and 
morphology of sperm (Schon and Blottner, 2009).  Spermatogenesis is also a temperature 
sensitive process and slight increases in temperature can disrupt the process due to 
hypoxia (Lue et al., 1999).  However, in one study in the stallion, scrotal insulation, had 
little effect on sperm maturation in the epidiymis, but was more likely to impact primary 
spermatocytes (Love and Kenney, 1999).  While there was no evaluation of 
morphological changes due to increasing temperatures, the higher temperatures in the 
summer months compared to winter months may have impacted percentage 
morphologically normal sperm cells in the Przewalski’s stallions.
Because there was little variation in motility, progressive motility, total 
progressively motile sperm, and total testicular volume, variable analysis on these 
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seminal traits were not performed.  Because stallions in this study were only collected 
once in each season, variation due to stallion and collection techniques may have made it 
more difficult to detect seasonal effects.  In future studies, more frequent collections in 
each season should be conducted in order to determine seasonal effects on seminal traits 
in Przewalski’s stallions.
More recent research (Scaramuzzi and Martin, 2008) has also shown that nutrition 
has a an impact on seasonality in that horses on a high nutritional plan in the winter 
months show fewer signs of anestrus or decreased reproductive activity.  Przewalski’s 
stallions in the wild survive in the Gobi Dessert where food is scarce in the winter months 
due to temperatures reaching -15! to -18! C (Groves, 1994).  In the spring and summer 
months, grass is plentiful and condition of Przewalski’s horses improves.  At the SCBI
and the Wilds, all horses were maintained on similar diets throughout the year, and, at the 
SCBI, weight is monitored regularly which influences diets of each individual animal.  
As a result, there is little fluctuation in weight of animals from winter to summer 
compared to animals in the wild.  As there is limited research in nutrition of Przewalski’s 
horses, especially in relation to reproduction, it is possible that condition of stallions may 
have masked seasonal effects more than would be expected of the in situ population.
It has been shown in the domestic stallion that frequency of collections influences 
both quality and quantity of spermatozoa due to extragonadal reserves (Picketts, 1985;
Blanchard et al, 2003).  These reserves are primarily stored in the tail of the epididymis 
and can be 3 -4 times higher than the actual daily sperm output for the stallion, thus 
impacting total sperm output (Pickett, 1993). Sperm reserves of sexually rested stallions 
also increase with age and approximately twice the number of spermatozoa are present in 
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the body of the epididymis of 10 to 16 year old stallions (9.5 x 10 
9
) compared to 2 to 4 
year old stallions (4.2 x 10 
9
In this study, age and coefficient of inbreeding were heavily confounded in the 
overall stallion effect; therefore, we were unable to determine whether age or inbreeding 
had a significant impact in seminal parameters.  Stallion effect did have a significant 
effect on all traits (P< 0.05) except seminal pH.  One study (Durrant, 1990) did state that 
age did not have a significant effect on seminal traits. Contrary to this, in domestic 
stallions > 11 years of age, there is a reduced quality in seminal parameters (Dowsen, 
1996).  The population of ex situ Przewalski’s horses in North America are composed of 
mostly older animals where the mean age is 13.62 # 1.08 years and 26 of 35 total 
stallions (74.29%) in the SSP population are > 11 years of age (Powell, 2010).  In the 
current study, 10 of the 14 stallions studied (71.4%) were > 11 years of age.  Even though 
the population in this study is similar in age to the overall SSP population, having such a 
high number of older stallions in a study may have impacted the overall seminal traits. It 
has been shown in the domestic horse, that daily sperm output and testicular size 
decreases in stallions >13 years of age, although percentage motility and morphologically 
normal sperm were not impacted (Pickett et al. 1988).  This is expected because it was 
determined that efficiency of sperm production is lower in older stallions (Amann et al.,
; Amann et al., 1979).   Because of this, estimation of total 
sperm numbers based on a single semen sample collected from a sexually rested stallion 
may be increased (Love, 1997).  In the current study, stallions were collected once in a 3-
month period. In future, more frequent collections from stallions that are not sexually 
rested may show less variability in seminal traits and be more representative of actual 
sperm quality in a breeding situation.
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1979).  Other studies have also determined that Sertoli cell numbers in the testes decrease 
in stallions with age (Johnson and Thompson, 1983).  This would indicate that sperm 
production would be decreased due to not only decreased hormone production but also 
decreased supporting cells in the testicles. Future studies need to look at seminal traits 
stallions over time in order to assess seminal traits and whether they change in individual 
stallions with age.
In summary, we determined that individual stallion effect had a significant impact 
on seminal traits in Przewalski’s stallions.  Since the stallion effect includes individual, 
age and genetics, all of these factors could be impacting our data.  Based on study design, 
we were unable to analyze age and inbreeding as separate effects from individuals, 
therefore we were unable to determine whether inbreeding has a significant effect on 
seminal traits of Przewalski’s stallions.  Also, this is the first study to assess seminal traits 
in Przewalski’s stallions over multiple years, which is important in characterizing 
reproductive physiology in this species.  Because of this we further defined seasonal 
variation in traits such as concentration, morphology, pH and volume.  What is most 
concerning is the low number of morphologically normal sperm cells among all males,
which may be one of the causes of sub-fertility in the ex situ population.  Most 
importantly, we have determined that there is an increase in total sperm numbers and 
morphologically normal sperm cells during spring, which correlates with the breeding 
season.  Since epididymal and testicular function has been shown to vary according to 
season in other seasonal breeders, these data could also indicate a change in 
spermatogenesis in the Przewalski’s horse that could be related to photoperiod or 
nutrition.  Future studies need to be conducted to determine whether cryosensitivity and 
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fertility also varies with season, which is very important for long term preservation of 
valuable genetics in this population.
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CHAPTER FIVE
Overall Significance and Future Directions
The research in this dissertation has further characterized many aspects of male and 
female reproductive biology in the Przewalski’s horse.  Because we had unique handling 
facilities, we were able to monitor follicular development in Przewalski’s mares, 
something that has yet to be accomplished in wild equids.  By combining follicular and 
endocrine data, we have developed a greater understanding of reproductive physiology in 
Przewalski’s mares by reaffirming previous data on the length of estrus and also defining 
the length of diestrus.  We were also able to describe follicular changes in relation to 
hormonal changes which aided in the detection of sub-fertility in this population.  It was 
determined that mean kinship is, in fact, impacting normal reproductive patterns in 
mares.  This is especially concerning because there are no new founder animals that may 
contribute to improving heterozygosity in this population.  Because the SSP population 
has an uneven representation of some founders, future research should be conducted in 
order to determine whether certain founder genetics are impacting reproduction in
Przewalski’s mares.
In our second study, we were able to demonstrate that the estrous cycle of 
Przewalski’s mares can be manipulated by exogenous progestagens and gonadotroophins.  
Injectable altrenogest was as efficacious as the oral form, which is advantageous in wild 
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equids that are difficult treat with oral meds.  This study also further confirmed the 
similarities between domestic mares and Przewalski’s mares and their cyclic patterns.  
This is important because assisted reproductive technologies, such as AI, that are 
commonly utilized in the domestic horse for breeding management, may be applicable to 
the breeding management of Przewalski’s horses.  
In our third study, we were able to provide extensive information on seminal traits 
from Przewalski’s stallions.  We were also able to show, through predictive analysis, that 
there are seasonal variations in some of these traits.  Because these changes may reflect 
testicular or endocrine function, it is important to understand these changes, especially 
when designing methods of cryopreservation.  What was most alarming about this study 
was the high percentage of morphologically abnormal sperm detected among all stallions.  
While we were unable to show that inbreeding impacted seminal traits, research in other 
ungulate species has shown that inbreeding impacts percentage normal sperm.  
This research is important because it is the first to demonstrate that genetic 
management of Przewalski’s horses is important for long term survival of this species.
Currently, breeding management of Przewalski’s horses is managed by the mean kinship 
values, which indicates inbreeding of offspring of potential breeding pairs, yet this is not 
always a good indication of development of genetic defects. In other wildlife species, 
research is starting to show that breeding management based on mean kinship is not 
effective at preventing development of deleterious genes because it is only an indication 
of homozygosity. Because there is evidence that inbreeding is impacting infertility, future 
research should focus on whether over represented founders in the population are actually 
contributing deleterious genes that are impacting reproductive fitness in mares and 
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stallions.  This could provide information that would encourage breeding of 
underrepresented founder genetics in this population.  
While we were not able to determine that inbreeding or age had an impact on sperm 
output in Przewalski’s stallions, we did determine that there is a high percentage of 
abnormal spermatozoa in this population of stallions.  The most prevalent abnormality 
was the presence of proximal cytoplasmic droplets, which, in many species, indicates a 
possible sperm defect that occurs during spermiogenesis (Nöthling et al., 1997).  The fact 
that this defect was so prevalent in this population could indicate that there is an issue in 
the population.  We did not assess inbreeding in relation to defects, so future research 
should focus on particular morphological defects in relation to genetics of the population.  
While sub-fertility has been described with these defects in the dog, there is no research 
to indicate whether the presence of PCDs impact fertility in the Przewalski’s horse.  
Future research should be focused on whether the morphological defects that we have 
detected in this population can be overcome by assisted reproductive technologies, such 
as artificial insemination.
We were able to determine that Przewalski’s mares have a similar reproductive 
cycle to the domestic horse.  We were also able to show that mares have a similar 
response to estrous manipulation when given therapies that are used in domestic mares.  
This is important because ART in the domestic mare can be utilized for breeding 
management of Przewalski’s mares.  Future research should focus on describing LH in 
the Przewalski’s mare, which would provide a better understanding of the physiology of 
ovulation.  Development of artificial insemination, embryo transfer and in vitro 
fertilization in this species would also aid in better long term management of this species.
134
While development of ARTs is crucial, it is important to stress that genetic research 
in this species is necessary in the short term.  Now that entire genome the domestic horse 
has been described, it has been shown that there are many similarities to the human 
genome.  This makes the possibilities for looking at genetic changes in the Przewalski’s
horse limitless and, because they are an inbred population, they could serve as a model 







In order to perform repeated follicular assessments of Przewalski’s mares, a training program 
was initiated to acclimatize mares to repeated procedures without requiring frequent sedation or 
anesthesia.  Both the Smithsonian Conservation Biology Institute (SCBI) and the Wilds had 
incorporated a hydraulic tamer system (Fauna Research, Red Banks, NY, USA) into handling 
facilities for large ungulates.  At SCBI, the tamer was located in the hoofstock barn at the end of a 
chute system designed for movement of animals (Figure 1).  At the Wilds, the tamer system was 
connected to the hoofstock hospital and was connected to a chute system which connected several 
enclosures (Figure 2).
The hydraulic tamer is a mechanized system that is designed to handle large ungulate species 
safely so that sedation and anesthesia is not required for repeated procedures (Figure 3).  The 
hydraulic tamer actually immobilizes an animal by lifting it off the ground so that it is unable to move 
forward. Two padded walls hold the animal in place:  One wall is fixed while the other is moveable.  
The moveable side is connected to hydraulics that is controlled by an operator.  There is also a safety 
mechanism that releases the hydraulics when the pressure is higher than is deemed comfortable for the 
animal.  Both the moveable and fixed sides are able to tilt at slight angles so that animals of different 
sizes may be lifted for procedures.
Mares at SCBI (n = 14) were trained four months prior to research procedures.  At the start of 
the training period, mares were run, once per week for a three week period, through the chute system 
with the hydraulic tamer fully open as part of their movement from barn to pasture.  Mares were then 
run through the chute system with the hydraulic tamer fully open three days a week as part of their 
movement from barn to pasture for one week.  Each week after that, the hydraulic tamer was closed 
gradually so that the width between outer and inner pads decreased slightly.  Once the tamer pads 
were at a diameter that was deemed satisfactory for lifting animals (Figure 4), each mare was then 
walked through the chute system and stopped in the tamer briefly by closing the front door of the 
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tamer.  After 2 – 4 seconds, the door was opened and the mare was allowed out of tamer.  This was 
conducted for one week.  Mares were then kept in the tamer by closing both front and back door.  
Once each mare was quiet, the front door was opened in order to encourage mares to not struggle in 
the tamer.  
The next stage of the training was to lift mares with the hydraulic tamer.  Each mare was lifter 
for 2 – 4 seconds and then let down.  After the mares were let down, the front door was opened to 
release the mare once she was quiet.  Each mare was rewarded with an apple biscuit after each 
attempt.  Mares were lifted once per week for a four-week period.  Two other days per week, each 
mare was stopped in the tamer without being lifted.  The other two days, mares ran through the tamer 
system without being stopped to acclimatize mares to tamer procedure and also so that animals would 
not anticipate procedures each time they were run through the chute system.
After the training period, mares were then examined three days per week (Monday, 
Wednesday and Friday) using rectal ultrasonagraphy.  Each mare was moved into the tamer and lifted.  
Feces were evacuated from the rectum and the linear array probe was introduced in a gloved hand 
(Sonovet 2000, Medison America, Inc., Cypress, CA, USA).  Both left and right ovaries were then 
examined for structures (follicles, anovulatory follicle, corpora lutea), which were noted.  Both uterine 
horns and the uterine body were then examined for edema and uterine fluid, which was noted if 
present.  Once the exam was complete, mares were placed on the ground and the front door was 
opened so that mares could leave the tamer.  Each mare was rewarded with an apple biscuit after each 
examination.
Each examination performed was kept under a five-minute period.  If a mare was not picked 
up correctly after three attempts, no examination was performed that day.  Also, if a mare struggled or 
appeared too stressed, she was released and no examination was performed on that day.  On days that 
examinations were not performed, mares were run through the chute system with the tamer fully open.  
When research studies were not being conducted, mares were run through the chute system 1 – 3 days 
per week as part of their movement from barn to pasture.
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At the Wilds, mares used for the research study (n = 5) were moved to the hoofstock hospital 
2 – 4 weeks prior to research trial.  Because the tamer was used for other procedures, mares were only 
run through the chute system on days of examination.  Rectal examinations were performed as 
described above on the same days as examinations at SCBI.  Once the research study was complete, 
mares were then returned to pasture.
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Figure 1:  Schematic of chute and tamer in hoofstock barn (SCBI).  Movement pattern is depicted by 
numbers: 1) mares brought into holding area in small groups (1 – 4 individuals); 2) individual mare 
led into chute system and weighed on scale if needed; 3) each mare was then run down one chute 
towards tamer; 4) examination in tamer or run through on off days; and 5) mares released to barn area 
after examination and given apple biscuit.
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Figure 2:  Schematic diagram of chute and tamer system at the Wilds.  Mares for research were held 
in holding pen (1).  Movement pattern was as follows: 1) Individual mare led out of holding pen; 2) 
mare led down the chute area with a series of gates that close once mare has passed through; 3) mare 
continues down chute area ; 4) push gate allows mare to enter tamer without backing up; 5) rectal 
examination is performed; and 6) mares are held in small holding pen until examinations are complete 
and are then lead back up chute to holding pen 1.
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Figure 3:  Photograph of hydraulic tamer used for rectal examinations of Przewalski’s mares.  The 
visible side is the moveable wall of the tamer that is used to widen the diameter between inner pads.
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Figure 4:  Photograph of tamer demonstrating the width of the pads when open for procedures.  The 
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